0000754811 U S GLOBAL INVESTORS INC false --06-30 Q3 2025 0 0 4,611 6,204 0 0 0.025 0.025 28,000,000 28,000,000 13,866,999 13,866,999 11,153,193 11,753,483 0.025 0.025 4,500,000 4,500,000 0 0 0.025 0.025 3,500,000 3,500,000 2,068,549 2,068,549 2,068,549 2,068,549 2,713,806 2,113,516 10.5 http://fasb.org/us-gaap/2025#InvestmentIncomeNet http://fasb.org/us-gaap/2025#OtherComprehensiveIncomeLossNetOfTax 362,000 0 0 http://fasb.org/us-gaap/2025#OtherNonoperatingIncome http://fasb.org/us-gaap/2025#OtherNonoperatingIncome http://fasb.org/us-gaap/2025#OtherNonoperatingIncome http://fasb.org/us-gaap/2025#OtherNonoperatingIncome 0 6.05 2,000 2.74 6 6 0 0 0 0 0 0 0 0 false false false false Represents the change in present value attributable to the passage of time included in interest income. Held-to-maturity debt investments are carried at amortized cost, net of allowance for credit losses, and the fair value is classified as Level 2 according to the fair value hierarchy. Other investments include equity securities without readily determinable fair values that are adjusted as a result of the measurement alternative. There were no adjustments during the nine months ended March 31, 2025. Includes net unrealized and realized losses of $775,000 as a result of the measurement alternative for the six months ended December 31, 2023. There were no amounts included as a result of the measurement alternative for the three and six months ended December 31, 2024, or for the three months ended December 31, 2023. Includes net unrealized and realized losses of $240,000 and $1.0 million as a result of the measurement alternative for the three and nine months ended March 31, 2024, respectively. There were no amounts included as a result of the measurement alternative for the three and nine months ended March 31, 2025. Other investments include equity securities without readily determinable fair values that were adjusted as a result of the measurement alternative on dates during the fiscal year ended June 30, 2024. These securities are classified as level 3 due to the infrequency of the observable price changes and/or restrictions on the shares. Principal payments of $750,000 are due quarterly with a final maturity date in January 2026. Represents changes in unrealized gains and losses related to embedded derivatives included within net investment income (loss) on the Consolidated Statements of Operations. 0000754811 2024-07-01 2025-03-31 xbrli:shares 0000754811 us-gaap:CommonClassAMember 2025-05-01 0000754811 us-gaap:CommonClassCMember 2025-05-01 thunderdome:item iso4217:USD 0000754811 2025-03-31 0000754811 2024-06-30 iso4217:USD xbrli:shares 0000754811 us-gaap:CommonClassAMember 2025-03-31 0000754811 us-gaap:CommonClassAMember 2024-06-30 0000754811 us-gaap:CommonClassBMember 2025-03-31 0000754811 us-gaap:CommonClassBMember 2024-06-30 0000754811 us-gaap:CommonClassCMember 2025-03-31 0000754811 us-gaap:CommonClassCMember 2024-06-30 0000754811 grow:InvestmentAdvisoryServicesMember 2024-07-01 2025-03-31 0000754811 grow:InvestmentAdvisoryServicesMember 2023-07-01 2024-03-31 0000754811 grow:InvestmentAdvisoryServicesMember 2025-01-01 2025-03-31 0000754811 grow:InvestmentAdvisoryServicesMember 2024-01-01 2024-03-31 0000754811 us-gaap:AdministrativeServiceMember 2024-07-01 2025-03-31 0000754811 us-gaap:AdministrativeServiceMember 2023-07-01 2024-03-31 0000754811 us-gaap:AdministrativeServiceMember 2025-01-01 2025-03-31 0000754811 us-gaap:AdministrativeServiceMember 2024-01-01 2024-03-31 0000754811 2023-07-01 2024-03-31 0000754811 2025-01-01 2025-03-31 0000754811 2024-01-01 2024-03-31 0000754811 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2024-06-30 0000754811 us-gaap:CommonClassCMember us-gaap:CommonStockMember 2024-06-30 0000754811 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0000754811 us-gaap:TreasuryStockCommonMember 2024-06-30 0000754811 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-30 0000754811 us-gaap:RetainedEarningsMember 2024-06-30 0000754811 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2024-07-01 2024-09-30 0000754811 us-gaap:CommonClassCMember us-gaap:CommonStockMember 2024-07-01 2024-09-30 0000754811 us-gaap:AdditionalPaidInCapitalMember 2024-07-01 2024-09-30 0000754811 us-gaap:TreasuryStockCommonMember 2024-07-01 2024-09-30 0000754811 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-07-01 2024-09-30 0000754811 us-gaap:RetainedEarningsMember 2024-07-01 2024-09-30 0000754811 2024-07-01 2024-09-30 0000754811 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2024-09-30 0000754811 us-gaap:CommonClassCMember us-gaap:CommonStockMember 2024-09-30 0000754811 us-gaap:AdditionalPaidInCapitalMember 2024-09-30 0000754811 us-gaap:TreasuryStockCommonMember 2024-09-30 0000754811 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-09-30 0000754811 us-gaap:RetainedEarningsMember 2024-09-30 0000754811 2024-09-30 0000754811 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2024-10-01 2024-12-31 0000754811 us-gaap:CommonClassCMember us-gaap:CommonStockMember 2024-10-01 2024-12-31 0000754811 us-gaap:AdditionalPaidInCapitalMember 2024-10-01 2024-12-31 0000754811 us-gaap:TreasuryStockCommonMember 2024-10-01 2024-12-31 0000754811 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-10-01 2024-12-31 0000754811 us-gaap:RetainedEarningsMember 2024-10-01 2024-12-31 0000754811 2024-10-01 2024-12-31 0000754811 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2024-12-31 0000754811 us-gaap:CommonClassCMember us-gaap:CommonStockMember 2024-12-31 0000754811 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0000754811 us-gaap:TreasuryStockCommonMember 2024-12-31 0000754811 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0000754811 us-gaap:RetainedEarningsMember 2024-12-31 0000754811 2024-12-31 0000754811 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2025-01-01 2025-03-31 0000754811 us-gaap:CommonClassCMember us-gaap:CommonStockMember 2025-01-01 2025-03-31 0000754811 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0000754811 us-gaap:TreasuryStockCommonMember 2025-01-01 2025-03-31 0000754811 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-01-01 2025-03-31 0000754811 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0000754811 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2025-03-31 0000754811 us-gaap:CommonClassCMember us-gaap:CommonStockMember 2025-03-31 0000754811 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0000754811 us-gaap:TreasuryStockCommonMember 2025-03-31 0000754811 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-03-31 0000754811 us-gaap:RetainedEarningsMember 2025-03-31 0000754811 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2023-06-30 0000754811 us-gaap:CommonClassCMember us-gaap:CommonStockMember 2023-06-30 0000754811 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0000754811 us-gaap:TreasuryStockCommonMember 2023-06-30 0000754811 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0000754811 us-gaap:RetainedEarningsMember 2023-06-30 0000754811 2023-06-30 0000754811 us-gaap:AccountingStandardsUpdate201613Member srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:CommonClassAMember us-gaap:CommonStockMember 2023-06-30 0000754811 us-gaap:AccountingStandardsUpdate201613Member srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:CommonClassCMember us-gaap:CommonStockMember 2023-06-30 0000754811 us-gaap:AccountingStandardsUpdate201613Member srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0000754811 us-gaap:AccountingStandardsUpdate201613Member srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:TreasuryStockCommonMember 2023-06-30 0000754811 us-gaap:AccountingStandardsUpdate201613Member srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0000754811 us-gaap:AccountingStandardsUpdate201613Member srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:RetainedEarningsMember 2023-06-30 0000754811 us-gaap:AccountingStandardsUpdate201613Member srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2023-06-30 0000754811 us-gaap:AccountingStandardsUpdate201613Member srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember us-gaap:CommonClassAMember us-gaap:CommonStockMember 2023-06-30 0000754811 us-gaap:AccountingStandardsUpdate201613Member srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember us-gaap:CommonClassCMember us-gaap:CommonStockMember 2023-06-30 0000754811 us-gaap:AccountingStandardsUpdate201613Member srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0000754811 us-gaap:AccountingStandardsUpdate201613Member srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember us-gaap:TreasuryStockCommonMember 2023-06-30 0000754811 us-gaap:AccountingStandardsUpdate201613Member srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0000754811 us-gaap:AccountingStandardsUpdate201613Member srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember us-gaap:RetainedEarningsMember 2023-06-30 0000754811 us-gaap:AccountingStandardsUpdate201613Member srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2023-06-30 0000754811 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2023-07-01 2023-09-30 0000754811 us-gaap:CommonClassCMember us-gaap:CommonStockMember 2023-07-01 2023-09-30 0000754811 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0000754811 us-gaap:TreasuryStockCommonMember 2023-07-01 2023-09-30 0000754811 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-07-01 2023-09-30 0000754811 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0000754811 2023-07-01 2023-09-30 0000754811 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2023-09-30 0000754811 us-gaap:CommonClassCMember us-gaap:CommonStockMember 2023-09-30 0000754811 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0000754811 us-gaap:TreasuryStockCommonMember 2023-09-30 0000754811 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-09-30 0000754811 us-gaap:RetainedEarningsMember 2023-09-30 0000754811 2023-09-30 0000754811 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2023-10-01 2023-12-31 0000754811 us-gaap:CommonClassCMember us-gaap:CommonStockMember 2023-10-01 2023-12-31 0000754811 us-gaap:AdditionalPaidInCapitalMember 2023-10-01 2023-12-31 0000754811 us-gaap:TreasuryStockCommonMember 2023-10-01 2023-12-31 0000754811 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-10-01 2023-12-31 0000754811 us-gaap:RetainedEarningsMember 2023-10-01 2023-12-31 0000754811 2023-10-01 2023-12-31 0000754811 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2023-12-31 0000754811 us-gaap:CommonClassCMember us-gaap:CommonStockMember 2023-12-31 0000754811 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0000754811 us-gaap:TreasuryStockCommonMember 2023-12-31 0000754811 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0000754811 us-gaap:RetainedEarningsMember 2023-12-31 0000754811 2023-12-31 0000754811 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2024-01-01 2024-03-31 0000754811 us-gaap:CommonClassCMember us-gaap:CommonStockMember 2024-01-01 2024-03-31 0000754811 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0000754811 us-gaap:TreasuryStockCommonMember 2024-01-01 2024-03-31 0000754811 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0000754811 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0000754811 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2024-03-31 0000754811 us-gaap:CommonClassCMember us-gaap:CommonStockMember 2024-03-31 0000754811 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0000754811 us-gaap:TreasuryStockCommonMember 2024-03-31 0000754811 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0000754811 us-gaap:RetainedEarningsMember 2024-03-31 0000754811 2024-03-31 0000754811 grow:TradingSecuritiesCurrentMember 2024-07-01 2025-03-31 0000754811 grow:TradingSecuritiesCurrentMember 2023-07-01 2024-03-31 0000754811 grow:TradingSecuritiesNoncurrentMember 2024-07-01 2025-03-31 0000754811 grow:TradingSecuritiesNoncurrentMember 2023-07-01 2024-03-31 0000754811 us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember 2025-03-31 0000754811 us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember 2024-06-30 0000754811 us-gaap:AccountingStandardsUpdate201613Member 2023-07-01 0000754811 us-gaap:AccountingStandardsUpdate201613Member srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2023-07-01 xbrli:pure 0000754811 grow:USGlobalInvestorsFundsMember 2025-03-31 0000754811 grow:USGlobalInvestorsFundsMember 2024-06-30 0000754811 us-gaap:FairValueInputsLevel3Member grow:WarrantsAndConvertibleDebenturesMember grow:AvailableforsaleSecuritiesAndEquitySecuritiesMember grow:HiveBlockchainTechnologiesLtdMember 2025-03-31 0000754811 us-gaap:FairValueInputsLevel3Member grow:WarrantsAndConvertibleDebenturesMember grow:AvailableforsaleSecuritiesAndEquitySecuritiesMember grow:HiveBlockchainTechnologiesLtdMember 2024-06-30 0000754811 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember grow:EquitySecuritiesDomesticMember 2025-03-31 0000754811 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember grow:EquitySecuritiesDomesticMember 2025-03-31 0000754811 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember grow:EquitySecuritiesDomesticMember 2025-03-31 0000754811 us-gaap:FairValueMeasurementsRecurringMember grow:EquitySecuritiesDomesticMember 2025-03-31 0000754811 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember grow:EquitySecuritiesInternationalMember 2025-03-31 0000754811 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember grow:EquitySecuritiesInternationalMember 2025-03-31 0000754811 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember grow:EquitySecuritiesInternationalMember 2025-03-31 0000754811 us-gaap:FairValueMeasurementsRecurringMember grow:EquitySecuritiesInternationalMember 2025-03-31 0000754811 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember grow:ExchangeTradedFundsGlobalEquityMember 2025-03-31 0000754811 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember grow:ExchangeTradedFundsGlobalEquityMember 2025-03-31 0000754811 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember grow:ExchangeTradedFundsGlobalEquityMember 2025-03-31 0000754811 us-gaap:FairValueMeasurementsRecurringMember grow:ExchangeTradedFundsGlobalEquityMember 2025-03-31 0000754811 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember grow:MutualFundsFixedIncomeMember 2025-03-31 0000754811 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember grow:MutualFundsFixedIncomeMember 2025-03-31 0000754811 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember grow:MutualFundsFixedIncomeMember 2025-03-31 0000754811 us-gaap:FairValueMeasurementsRecurringMember grow:MutualFundsFixedIncomeMember 2025-03-31 0000754811 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember grow:MutualFundsGlobalEquityMember 2025-03-31 0000754811 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember grow:MutualFundsGlobalEquityMember 2025-03-31 0000754811 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember grow:MutualFundsGlobalEquityMember 2025-03-31 0000754811 us-gaap:FairValueMeasurementsRecurringMember grow:MutualFundsGlobalEquityMember 2025-03-31 0000754811 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2025-03-31 0000754811 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2025-03-31 0000754811 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2025-03-31 0000754811 us-gaap:FairValueMeasurementsRecurringMember 2025-03-31 0000754811 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2025-03-31 0000754811 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2025-03-31 0000754811 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2025-03-31 0000754811 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2025-03-31 0000754811 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ConvertibleDebtSecuritiesMember 2025-03-31 0000754811 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ConvertibleDebtSecuritiesMember 2025-03-31 0000754811 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ConvertibleDebtSecuritiesMember 2025-03-31 0000754811 us-gaap:FairValueMeasurementsRecurringMember us-gaap:ConvertibleDebtSecuritiesMember 2025-03-31 0000754811 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:OtherLongTermInvestmentsMember 2025-03-31 0000754811 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:OtherLongTermInvestmentsMember 2025-03-31 0000754811 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:OtherLongTermInvestmentsMember 2025-03-31 0000754811 us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:OtherLongTermInvestmentsMember 2025-03-31 0000754811 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember grow:EquitySecuritiesInternationalMember 2024-06-30 0000754811 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember grow:EquitySecuritiesInternationalMember 2024-06-30 0000754811 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember grow:EquitySecuritiesInternationalMember 2024-06-30 0000754811 us-gaap:FairValueMeasurementsRecurringMember grow:EquitySecuritiesInternationalMember 2024-06-30 0000754811 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember grow:MutualFundsFixedIncomeMember 2024-06-30 0000754811 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember grow:MutualFundsFixedIncomeMember 2024-06-30 0000754811 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember grow:MutualFundsFixedIncomeMember 2024-06-30 0000754811 us-gaap:FairValueMeasurementsRecurringMember grow:MutualFundsFixedIncomeMember 2024-06-30 0000754811 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember grow:MutualFundsGlobalEquityMember 2024-06-30 0000754811 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember grow:MutualFundsGlobalEquityMember 2024-06-30 0000754811 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember grow:MutualFundsGlobalEquityMember 2024-06-30 0000754811 us-gaap:FairValueMeasurementsRecurringMember grow:MutualFundsGlobalEquityMember 2024-06-30 0000754811 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2024-06-30 0000754811 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2024-06-30 0000754811 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2024-06-30 0000754811 us-gaap:FairValueMeasurementsRecurringMember 2024-06-30 0000754811 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2024-06-30 0000754811 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2024-06-30 0000754811 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2024-06-30 0000754811 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2024-06-30 0000754811 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ConvertibleDebtSecuritiesMember 2024-06-30 0000754811 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ConvertibleDebtSecuritiesMember 2024-06-30 0000754811 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ConvertibleDebtSecuritiesMember 2024-06-30 0000754811 us-gaap:FairValueMeasurementsRecurringMember us-gaap:ConvertibleDebtSecuritiesMember 2024-06-30 0000754811 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:OtherLongTermInvestmentsMember 2024-06-30 0000754811 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:OtherLongTermInvestmentsMember 2024-06-30 0000754811 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:OtherLongTermInvestmentsMember 2024-06-30 0000754811 us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:OtherLongTermInvestmentsMember 2024-06-30 0000754811 us-gaap:FairValueInputsLevel1Member us-gaap:CommonStockMember grow:HiveBlockchainTechnologiesLtdMember 2025-01-31 0000754811 us-gaap:CommonStockMember grow:HiveBlockchainTechnologiesLtdMember 2025-01-31 0000754811 grow:ConvertibleSecuritiesMember grow:HiveBlockchainTechnologiesLtdMember 2021-01-31 0000754811 grow:UnsecuredConvertibleDebenturesMember us-gaap:ConvertibleDebtSecuritiesMember grow:HiveBlockchainTechnologiesLtdMember 2021-03-31 0000754811 grow:CommonSharesPurchaseWarrantsMember grow:HiveBlockchainTechnologiesLtdMember 2021-03-31 0000754811 grow:UnsecuredConvertibleDebenturesMember us-gaap:ConvertibleDebtSecuritiesMember grow:HiveBlockchainTechnologiesLtdMember 2021-01-31 iso4217:CAD xbrli:shares 0000754811 grow:CommonSharesPurchaseWarrantsMember grow:HiveBlockchainTechnologiesLtdMember 2021-01-31 0000754811 grow:UnsecuredConvertibleDebenturesMember us-gaap:ConvertibleDebtSecuritiesMember grow:HiveBlockchainTechnologiesLtdMember 2025-03-31 0000754811 us-gaap:EstimateOfFairValueFairValueDisclosureMember grow:UnsecuredConvertibleDebenturesMember grow:HiveBlockchainTechnologiesLtdMember 2021-01-12 0000754811 grow:UnsecuredConvertibleDebenturesMember grow:HiveBlockchainTechnologiesLtdMember 2021-01-12 2021-01-12 0000754811 grow:UnsecuredConvertibleDebenturesMember grow:HiveBlockchainTechnologiesLtdMember 2025-03-31 0000754811 grow:UnsecuredConvertibleDebenturesMember grow:HiveBlockchainTechnologiesLtdMember 2024-06-30 0000754811 us-gaap:ConvertibleDebtSecuritiesMember grow:ValuationTechniqueBinomialLatticeModelMember 2025-03-31 0000754811 us-gaap:MeasurementInputPriceVolatilityMember grow:ValuationTechniqueBinomialLatticeModelMember 2025-03-31 0000754811 us-gaap:MeasurementInputCreditSpreadMember grow:ValuationTechniqueBinomialLatticeModelMember 2025-03-31 0000754811 us-gaap:MeasurementInputRiskFreeInterestRateMember grow:ValuationTechniqueBinomialLatticeModelMember 2025-03-31 0000754811 us-gaap:ConvertibleDebtSecuritiesMember grow:ValuationTechniqueBinomialLatticeModelMember 2024-06-30 0000754811 us-gaap:MeasurementInputPriceVolatilityMember grow:ValuationTechniqueBinomialLatticeModelMember 2024-06-30 0000754811 us-gaap:MeasurementInputCreditSpreadMember us-gaap:ValuationTechniqueOptionPricingModelMember 2024-06-30 0000754811 us-gaap:MeasurementInputRiskFreeInterestRateMember grow:ValuationTechniqueBinomialLatticeModelMember 2024-06-30 0000754811 grow:EquitySecuritiesDomesticMember 2025-03-31 0000754811 grow:EquitySecuritiesInternationalMember 2025-03-31 0000754811 grow:ExchangeTradedFundsGlobalEquityMember 2025-03-31 0000754811 grow:MutualFundsFixedIncomeMember 2025-03-31 0000754811 grow:MutualFundsGlobalEquityMember 2025-03-31 0000754811 us-gaap:CorporateDebtSecuritiesMember 2025-03-31 0000754811 us-gaap:CorporateDebtSecuritiesMember 2024-07-01 2025-03-31 0000754811 grow:EquitySecuritiesDomesticMember 2024-06-30 0000754811 grow:EquitySecuritiesInternationalMember 2024-06-30 0000754811 grow:MutualFundsFixedIncomeMember 2024-06-30 0000754811 grow:MutualFundsGlobalEquityMember 2024-06-30 0000754811 us-gaap:CorporateDebtSecuritiesMember 2024-06-30 0000754811 us-gaap:CorporateDebtSecuritiesMember 2023-07-01 2024-06-30 0000754811 us-gaap:ConvertibleDebtSecuritiesMember 2025-03-31 0000754811 us-gaap:ConvertibleDebtSecuritiesMember 2024-06-30 0000754811 us-gaap:AccountingStandardsUpdate201613Member srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2024-06-30 0000754811 grow:TheSonarCompanyMember 2025-03-31 0000754811 grow:TheSonarCompanyMember 2024-06-30 0000754811 grow:USGlobalETFsMember grow:InvestmentAndAdvisoryServicesMember 2024-07-01 2025-03-31 0000754811 grow:USGlobalETFsMember grow:InvestmentAndAdvisoryServicesMember 2023-07-01 2024-03-31 0000754811 grow:USGlobalETFsMember grow:InvestmentAndAdvisoryServicesMember 2025-01-01 2025-03-31 0000754811 grow:USGlobalETFsMember grow:InvestmentAndAdvisoryServicesMember 2024-01-01 2024-03-31 0000754811 grow:USGlobalInvestorsFundsMember grow:InvestmentAndAdvisoryServicesMember 2024-07-01 2025-03-31 0000754811 grow:USGlobalInvestorsFundsMember grow:InvestmentAndAdvisoryServicesMember 2023-07-01 2024-03-31 0000754811 grow:USGlobalInvestorsFundsMember grow:InvestmentAndAdvisoryServicesMember 2025-01-01 2025-03-31 0000754811 grow:USGlobalInvestorsFundsMember grow:InvestmentAndAdvisoryServicesMember 2024-01-01 2024-03-31 0000754811 grow:USGlobalInvestorsFundsMember us-gaap:InvestmentPerformanceMember 2024-07-01 2025-03-31 0000754811 grow:USGlobalInvestorsFundsMember us-gaap:InvestmentPerformanceMember 2023-07-01 2024-03-31 0000754811 grow:USGlobalInvestorsFundsMember us-gaap:InvestmentPerformanceMember 2025-01-01 2025-03-31 0000754811 grow:USGlobalInvestorsFundsMember us-gaap:InvestmentPerformanceMember 2024-01-01 2024-03-31 0000754811 grow:InvestmentAndAdvisoryServicesMember 2024-07-01 2025-03-31 0000754811 grow:InvestmentAndAdvisoryServicesMember 2023-07-01 2024-03-31 0000754811 grow:InvestmentAndAdvisoryServicesMember 2025-01-01 2025-03-31 0000754811 grow:InvestmentAndAdvisoryServicesMember 2024-01-01 2024-03-31 0000754811 grow:USGlobalInvestorsFundsMember us-gaap:AdministrativeServiceMember 2024-07-01 2025-03-31 0000754811 grow:USGlobalInvestorsFundsMember us-gaap:AdministrativeServiceMember 2023-07-01 2024-03-31 0000754811 grow:USGlobalInvestorsFundsMember us-gaap:AdministrativeServiceMember 2025-01-01 2025-03-31 0000754811 grow:USGlobalInvestorsFundsMember us-gaap:AdministrativeServiceMember 2024-01-01 2024-03-31 0000754811 grow:USGlobalETFsMember 2024-07-01 2025-03-31 0000754811 grow:USGlobalETFsMember 2025-01-01 2025-03-31 0000754811 grow:USGlobalETFsMember 2024-01-01 2024-03-31 0000754811 grow:USGlobalETFsMember 2023-07-01 2024-03-31 0000754811 grow:USGlobalJetsUCITSETFMember 2024-07-01 2025-03-31 0000754811 grow:USGlobalInvestorsFundsMember 2025-03-31 0000754811 grow:USGlobalInvestorsFundsMember 2025-01-01 2025-03-31 0000754811 grow:USGlobalInvestorsFundsMember 2024-07-01 2025-03-31 0000754811 grow:USGlobalInvestorsFundsMember 2024-01-01 2024-03-31 0000754811 grow:USGlobalInvestorsFundsMember 2023-07-01 2024-03-31 0000754811 grow:FundClientsMember 2025-03-31 0000754811 grow:FundClientsMember grow:USGlobalETFsMember 2025-03-31 0000754811 grow:FundClientsMember grow:USGlobalInvestorsFundsMember 2025-03-31 0000754811 grow:FundClientsMember 2024-06-30 0000754811 grow:FundClientsMember grow:USGlobalETFsMember 2024-06-30 0000754811 grow:FundClientsMember grow:USGlobalInvestorsFundsMember 2024-06-30 0000754811 us-gaap:GeneralAndAdministrativeExpenseMember 2025-01-01 2025-03-31 0000754811 us-gaap:GeneralAndAdministrativeExpenseMember 2024-07-01 2025-03-31 0000754811 us-gaap:GeneralAndAdministrativeExpenseMember 2024-01-01 2024-03-31 0000754811 us-gaap:GeneralAndAdministrativeExpenseMember 2023-07-01 2024-03-31 utr:Y 0000754811 us-gaap:OtherAssetsMember 2025-03-31 0000754811 us-gaap:OtherAssetsMember 2024-06-30 0000754811 grow:HiveBlockchainTechnologiesLtdMember 2025-03-31 0000754811 grow:HiveBlockchainTechnologiesLtdMember 2024-06-30 0000754811 us-gaap:LineOfCreditMember us-gaap:MoneyMarketFundsMember 2025-03-31 0000754811 grow:O2025M112DividendsMember 2025-01-01 2025-03-31 0000754811 grow:O2025M46DividendsMember srt:ScenarioForecastMember 2025-04-01 2025-06-30 0000754811 grow:ShareRepurchasePlanRenewalDecember2012December2020Member 2025-03-31 0000754811 grow:ShareRepurchasePlanRenewalDecember2012December2020Member 2022-02-24 0000754811 grow:ShareRepurchasePlanRenewalDecember2012December2020Member 2022-02-25 0000754811 grow:ShareRepurchasePlanRenewalDecember2012December2020Member 2024-09-19 0000754811 us-gaap:CommonClassAMember us-gaap:TreasuryStockCommonMember 2025-01-01 2025-03-31 0000754811 us-gaap:CommonClassAMember us-gaap:TreasuryStockCommonMember 2024-07-01 2025-03-31 0000754811 us-gaap:CommonClassAMember us-gaap:TreasuryStockCommonMember 2024-01-01 2024-03-31 0000754811 us-gaap:CommonClassAMember us-gaap:TreasuryStockCommonMember 2023-07-01 2024-03-31 0000754811 grow:Plan1989Member 2025-03-31 0000754811 grow:Plan1989Member 2024-03-31 0000754811 grow:Plan1997Member 2025-03-31 0000754811 grow:Plan1997Member 2024-03-31 utr:M 0000754811 us-gaap:EmployeeStockOptionMember 2025-01-01 2025-03-31 0000754811 us-gaap:EmployeeStockOptionMember 2024-07-01 2025-03-31 0000754811 us-gaap:EmployeeStockOptionMember 2025-01-01 2025-03-31 0000754811 us-gaap:EmployeeStockOptionMember 2024-07-01 2025-03-31 0000754811 us-gaap:EmployeeStockOptionMember 2024-01-01 2024-03-31 0000754811 us-gaap:EmployeeStockOptionMember 2023-07-01 2024-03-31 0000754811 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2024-06-30 0000754811 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2024-07-01 2025-03-31 0000754811 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2025-03-31 0000754811 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2023-06-30 0000754811 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2023-07-01 2024-03-31 0000754811 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2024-03-31 0000754811 grow:InvestmentManagementServicesMember 2024-07-01 2025-03-31 0000754811 grow:CorporateInvestmentsMember 2024-07-01 2025-03-31 0000754811 grow:InvestmentManagementServicesMember 2025-03-31 0000754811 grow:CorporateInvestmentsMember 2025-03-31 0000754811 grow:InvestmentManagementServicesMember 2023-07-01 2024-03-31 0000754811 grow:CorporateInvestmentsMember 2023-07-01 2024-03-31 0000754811 grow:InvestmentManagementServicesMember 2024-03-31 0000754811 grow:CorporateInvestmentsMember 2024-03-31 0000754811 grow:InvestmentManagementServicesMember 2025-01-01 2025-03-31 0000754811 grow:CorporateInvestmentsMember 2025-01-01 2025-03-31 0000754811 grow:InvestmentManagementServicesMember 2024-01-01 2024-03-31 0000754811 grow:CorporateInvestmentsMember 2024-01-01 2024-03-31 0000754811 grow:USGlobalETFsMember grow:InvestmentManagementServicesMember 2025-01-01 2025-03-31 0000754811 grow:USGlobalETFsMember grow:InvestmentManagementServicesMember 2024-07-01 2025-03-31 0000754811 grow:USGlobalETFsMember grow:InvestmentManagementServicesMember 2024-01-01 2024-03-31 0000754811 grow:USGlobalETFsMember grow:InvestmentManagementServicesMember 2023-07-01 2024-03-31 0000754811 grow:USGlobalInvestorsFundsMember grow:InvestmentManagementServicesMember 2025-01-01 2025-03-31 0000754811 grow:USGlobalInvestorsFundsMember grow:InvestmentManagementServicesMember 2024-07-01 2025-03-31 0000754811 grow:USGlobalInvestorsFundsMember grow:InvestmentManagementServicesMember 2024-01-01 2024-03-31 0000754811 grow:USGlobalInvestorsFundsMember grow:InvestmentManagementServicesMember 2023-07-01 2024-03-31

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

☒ Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended March 31, 2025

OR

☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from ____________ to ____________.

Commission File Number 0-13928

U.S. GLOBAL INVESTORS, INC.
(Exact name of registrant as specified in its charter)

Texas | 74-1598370
(State or other jurisdiction of incorporation or organization) | (IRS Employer Identification No.)
7900 Callaghan Road San Antonio, Texas | 78229 (Zip Code)
(Address of principal executive offices) |

(210) 308-1234

(Registrant’s telephone number, including area code)

Not Applicable

(Former name, former address, and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class | Trading symbol(s) | Name of each exchange on which registered
Class A common stock, $0.025 par value per share | GROW | NASDAQ Capital Market

Securities registered pursuant to Section 12(g) of the Act: None

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐ | Accelerated filer ☐
Non-accelerated filer ☒ | Smaller reporting company ☒
| Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

On May 1, 2025, there were 13,866,999 shares of Registrant’s class A nonvoting common stock issued and 11,077,531 shares of Registrant’s class A nonvoting common stock issued and outstanding; no shares of Registrant’s class B nonvoting common shares outstanding; and 2,068,549 shares of Registrant’s class C voting common stock issued and outstanding.

Table of Contents

TABLE OF CONTENTS

PART I. FINANCIAL INFORMATION | 1
ITEM 1. FINANCIAL STATEMENTS | 1
CONSOLIDATED BALANCE SHEETS (UNAUDITED) | 1
CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) | 2
CONSOLIDATED STATEMENTS COMPREHENSIVE INCOME (LOSS) (UNAUDITED) | 3
CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY (UNAUDITED) | 4
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) | 6
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) | 7
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS | 21
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK | 26
ITEM 4. CONTROLS AND PROCEDURES | 27
PART II. OTHER INFORMATION | 28
ITEM 1A. RISK FACTORS | 28
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS | 28
ITEM 5. OTHER INFORMATION | 28
ITEM 6. EXHIBITS | 29
SIGNATURES | 30

Table of Contents

PART I. FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

U.S. GLOBAL INVESTORS, INC.

CONSOLIDATED BALANCE SHEETS

|  | March 31, 2025 |  |  | June 30, 2024 |
(dollars in thousands) |  | (unaudited) |  |  |  |  |
Assets |  |  |  |  |  |  |  |
Current Assets |  |  |  |  |  |  |  |
Cash and cash equivalents |  | $ | 26,262 |  |  | $ | 27,399 |
Restricted cash |  |  | 1,000 |  |  |  | 1,000 |
Investments in trading securities at fair value, current |  |  | 9,692 |  |  |  | 9,644 |
Accounts and other receivables (net of allowance for credit losses of $0, and $0, respectively) |  |  | 1,033 |  |  |  | 1,047 |
Tax receivable |  |  | 662 |  |  |  | 729 |
Prepaid expenses |  |  | 650 |  |  |  | 498 |
Total Current Assets |  |  | 39,299 |  |  |  | 40,317 |
Net Property and Equipment |  |  | 1,112 |  |  |  | 1,154 |
Other Assets |  |  |  |  |  |  |  |
Deferred tax asset |  |  | 1,902 |  |  |  | 1,833 |
Investments in trading securities at fair value, non-current |  |  | 1,311 |  |  |  | 1,449 |
Investments in available-for-sale debt securities at fair value (amortized cost: $4,611, and $6,204, respectively) (net of allowance for credit losses of $0, and $0, respectively) |  |  | 2,302 |  |  |  | 4,414 |
Investments in held-to-maturity debt securities at amortized cost |  |  | 1,000 |  |  |  | 1,000 |
Less: Allowance for credit losses |  |  | (71 | ) |  |  | (132 | )
Investments in held-to-maturity debt securities, net of allowance for credit losses |  |  | 929 |  |  |  | 868 |
Other investments |  |  | 1,687 |  |  |  | 1,687 |
Financing lease, right of use assets |  |  | 16 |  |  |  | 38 |
Other assets, non-current |  |  | 200 |  |  |  | 203 |
Total Other Assets |  |  | 8,347 |  |  |  | 10,492 |
Total Assets |  | $ | 48,758 |  |  | $ | 51,963 |
Liabilities and Shareholders’ Equity |  |  |  |  |  |  |  |
Current Liabilities |  |  |  |  |  |  |  |
Accounts payable |  | $ | 1 |  |  | $ | 14 |
Accrued compensation and related costs |  |  | 328 |  |  |  | 609 |
Dividends payable |  |  | 300 |  |  |  | 313 |
Financing lease liability, short-term |  |  | 17 |  |  |  | 31 |
Other accrued expenses |  |  | 1,166 |  |  |  | 1,197 |
Total Current Liabilities |  |  | 1,812 |  |  |  | 2,164 |
Long-Term Liabilities |  |  |  |  |  |  |  |
Deferred tax liability |  |  | 8 |  |  |  | - |
Reserve for uncertain tax positions |  |  | 838 |  |  |  | 785 |
Financing lease liability, long-term |  |  | - |  |  |  | 8 |
Total Long-Term Liabilities |  |  | 846 |  |  |  | 793 |
Total Liabilities |  |  | 2,658 |  |  |  | 2,957 |
Commitments and Contingencies (Note 13) |  |  |  |  |  |  |  |
Shareholders’ Equity |  |  |  |  |  |  |  |
Common stock (class A) - $0.025 par value; nonvoting; 28,000,000 shares authorized; 13,866,999 shares issued at March 31, 2025, and June 30, 2024; 11,153,193 and 11,753,483 shares outstanding at March 31, 2025, and June 30, 2024, respectively |  |  | 347 |  |  |  | 347 |
Common stock (class B) - $0.025 par value; nonvoting; 4,500,000 shares authorized; no shares issued |  |  | - |  |  |  | - |
Convertible common stock (class C) - $0.025 par value; voting; 3,500,000 shares authorized; 2,068,549 shares issued and outstanding at March 31, 2025, and June 30, 2024 |  |  | 52 |  |  |  | 52 |
Additional paid-in-capital |  |  | 16,504 |  |  |  | 16,443 |
Treasury stock, class A shares at cost; 2,713,806 and 2,113,516 shares at March 31, 2025, and June 30, 2024, respectively |  |  | (7,394 | ) |  |  | (5,880 | )
Accumulated other comprehensive income, net of tax |  |  | 184 |  |  |  | 584 |
Retained earnings |  |  | 36,407 |  |  |  | 37,460 |
Total Shareholders’ Equity |  |  | 46,100 |  |  |  | 49,006 |
Total Liabilities and Shareholders’ Equity |  | $ | 48,758 |  |  | $ | 51,963 |

The accompanying notes are an integral part of these Consolidated Financial Statements.

Page 1

Table of Contents

U.S. GLOBAL INVESTORS, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

|  | Nine Months Ended |  |  | Three Months Ended |
|  | March 31, |  |  | March 31, |
(dollars in thousands, except per share data) |  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
Operating Revenues |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Advisory fees |  | $ | 6,400 |  |  | $ | 8,458 |  |  | $ | 2,072 |  |  | $ | 2,566 |
Administrative services fees |  |  | 92 |  |  |  | 86 |  |  |  | 31 |  |  |  | 27 |
Total Operating Revenues |  |  | 6,492 |  |  |  | 8,544 |  |  |  | 2,103 |  |  |  | 2,593 |
Operating Expenses |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Employee compensation and benefits |  |  | 3,597 |  |  |  | 3,445 |  |  |  | 1,290 |  |  |  | 1,209 |
General and administrative |  |  | 4,347 |  |  |  | 4,725 |  |  |  | 1,452 |  |  |  | 1,733 |
Advertising |  |  | 487 |  |  |  | 291 |  |  |  | 243 |  |  |  | 97 |
Depreciation |  |  | 50 |  |  |  | 163 |  |  |  | 11 |  |  |  | 41 |
Interest |  |  | 1 |  |  |  | 2 |  |  |  | - |  |  |  | 1 |
Total Operating Expenses |  |  | 8,482 |  |  |  | 8,626 |  |  |  | 2,996 |  |  |  | 3,081 |
Operating Income (Loss) |  |  | (1,990 | ) |  |  | (82 | ) |  |  | (893 | ) |  |  | (488 | )
Other Income (Loss) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net investment income (loss) |  |  | 1,819 |  |  |  | 1,363 |  |  |  | 548 |  |  |  | 460 |
Other income (loss) |  |  | 247 |  |  |  | 183 |  |  |  | 100 |  |  |  | 68 |
Total Other Income (Loss) |  |  | 2,066 |  |  |  | 1,546 |  |  |  | 648 |  |  |  | 528 |
Income (Loss) Before Income Taxes |  |  | 76 |  |  |  | 1,464 |  |  |  | (245 | ) |  |  | 40 |
Provision for Income Taxes |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Tax expense (benefit) |  |  | 229 |  |  |  | 446 |  |  |  | 137 |  |  |  | 75 |
Net Income (Loss) |  | $ | (153 | ) |  | $ | 1,018 |  |  | $ | (382 | ) |  | $ | (35 | )
Earnings (Loss) Per Share |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Basic Net Income (Loss) per share |  | $ | (0.01 | ) |  | $ | 0.07 |  |  | $ | (0.03 | ) |  | $ | (0.00 | )
Diluted Net Income (Loss) per share |  | $ | (0.01 | ) |  | $ | 0.07 |  |  | $ | (0.03 | ) |  | $ | (0.00 | )
Basic weighted average number of common shares outstanding |  |  | 13,414,873 |  |  |  | 14,278,691 |  |  |  | 13,023,636 |  |  |  | 14,077,042 |
Diluted weighted average number of common shares outstanding |  |  | 13,418,041 |  |  |  | 14,278,777 |  |  |  | 13,024,441 |  |  |  | 14,077,042 |

The accompanying notes are an integral part of these Consolidated Financial Statements.

Page 2

Table of Contents

U.S. GLOBAL INVESTORS, INC.

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (UNAUDITED)

|  | Nine Months Ended |  |  | Three Months Ended |
|  | March 31, |  |  | March 31, |
(dollars in thousands) |  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
Net Income (Loss) |  | $ | (153 | ) |  | $ | 1,018 |  |  | $ | (382 | ) |  | $ | (35 | )
Other Comprehensive Income (Loss) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Unrealized gains (losses) on available-for-sale securities arising during period, net of tax |  |  | 1 |  |  |  | 199 |  |  |  | (18 | ) |  |  | 79 |
Less: reclassification adjustment for gains included in net income (loss), net of tax |  |  | (401 | ) |  |  | (716 | ) |  |  | (106 | ) |  |  | (211 | )
Net change from available-for-sale securities |  |  | (400 | ) |  |  | (517 | ) |  |  | (124 | ) |  |  | (132 | )
Other Comprehensive Income (Loss) |  |  | (400 | ) |  |  | (517 | ) |  |  | (124 | ) |  |  | (132 | )
Total Comprehensive Income (Loss) |  | $ | (553 | ) |  | $ | 501 |  |  | $ | (506 | ) |  | $ | (167 | )

The accompanying notes are an integral part of these Consolidated Financial Statements.

Page 3

Table of Contents

U.S. GLOBAL INVESTORS, INC.

CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY (UNAUDITED)

|  | Common Stock |  |  | Convertible Common Stock |  |  |  |  |  |  | Treasury Stock |  |  | Accumulated |  |  |  |  |  |  |  |  |
|  | (class A) |  |  | (class C) |  |  | Additional |  |  |  |  |  |  |  |  |  |  | Other |  |  |  |  |  |  |  |  |
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | Paid-in |  |  |  |  |  |  |  |  |  |  | Comprehensive |  |  | Retained |  |  |  |  |
(dollars in thousands) |  | Shares |  |  | Par Value |  |  | Shares |  |  | Par Value |  |  | Capital |  |  | Shares |  |  | Cost |  |  | Income (Loss) |  |  | Earnings |  |  | Total |
Balance at June 30, 2024 |  |  | 13,866,999 |  |  | $ | 347 |  |  |  | 2,068,549 |  |  | $ | 52 |  |  | $ | 16,443 |  |  |  | 2,113,516 |  |  | $ | (5,880 | ) |  | $ | 584 |  |  | $ | 37,460 |  |  | $ | 49,006 |
Repurchases of shares of Common Stock (class A), including excise tax |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 197,887 |  |  |  | (525 | ) |  |  | - |  |  |  | - |  |  |  | (525 | )
Issuance of stock under ESPP of shares of Common Stock (class A) |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | (1 | ) |  |  | (6,665 | ) |  |  | 18 |  |  |  | - |  |  |  | - |  |  |  | 17 |
Dividends declared |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | (304 | ) |  |  | (304 | )
Other comprehensive income (loss), net of tax |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | (142 | ) |  |  | - |  |  |  | (142 | )
Net income (loss) |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 315 |  |  |  | 315 |
Balance at September 30, 2024 |  |  | 13,866,999 |  |  | $ | 347 |  |  |  | 2,068,549 |  |  | $ | 52 |  |  | $ | 16,442 |  |  |  | 2,304,738 |  |  | $ | (6,387 | ) |  | $ | 442 |  |  | $ | 37,471 |  |  | $ | 48,367 |
Repurchases of shares of Common Stock (class A), including excise tax |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 236,731 |  |  |  | (592 | ) |  |  | - |  |  |  | - |  |  |  | (592 | )
Issuance of stock under ESPP of shares of Common Stock (class A) |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | (3 | ) |  |  | (7,794 | ) |  |  | 22 |  |  |  | - |  |  |  | - |  |  |  | 19 |
Share-based compensation, net of tax |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 11 |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 11 |
Share-based compensation, adjustment for forfeitures, net of tax |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | (1 | ) |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | (1 | )
Dividends declared |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | (299 | ) |  |  | (299 | )
Other comprehensive income (loss), net of tax |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | (134 | ) |  |  | - |  |  |  | (134 | )
Net income (loss) |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | (86 | ) |  |  | (86 | )
Balance at December 31, 2024 |  |  | 13,866,999 |  |  | $ | 347 |  |  |  | 2,068,549 |  |  | $ | 52 |  |  | $ | 16,449 |  |  |  | 2,533,675 |  |  | $ | (6,957 | ) |  | $ | 308 |  |  | $ | 37,086 |  |  | $ | 47,285 |
Repurchases of shares of Common Stock (class A), including excise tax |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 187,987 |  |  |  | (459 | ) |  |  | - |  |  |  | - |  |  |  | (459 | )
Issuance of stock under ESPP of shares of Common Stock (class A) |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | (3 | ) |  |  | (7,856 | ) |  |  | 22 |  |  |  | - |  |  |  | - |  |  |  | 19 |
Share-based compensation, net of tax |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 58 |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 58 |
Dividends declared |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | (297 | ) |  |  | (297 | )
Other comprehensive income (loss), net of tax |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | (124 | ) |  |  | - |  |  |  | (124 | )
Net income (loss) |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | (382 | ) |  |  | (382 | )
Balance at March 31, 2025 |  |  | 13,866,999 |  |  | $ | 347 |  |  |  | 2,068,549 |  |  | $ | 52 |  |  | $ | 16,504 |  |  |  | 2,713,806 |  |  | $ | (7,394 | ) |  | $ | 184 |  |  | $ | 36,407 |  |  | $ | 46,100 |

Page 4

Table of Contents

U.S. GLOBAL INVESTORS, INC.

CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY (UNAUDITED) (CONTINUED)

|  | Common Stock |  |  | Convertible Common Stock |  |  |  |  |  |  | Treasury Stock |  |  | Accumulated |  |  |  |  |  |  |  |  |
|  | (class A) |  |  | (class C) |  |  | Additional |  |  |  |  |  |  |  |  |  |  | Other |  |  |  |  |  |  |  |  |
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | Paid-in |  |  |  |  |  |  |  |  |  |  | Comprehensive |  |  | Retained |  |  |  |  |
(dollars in thousands) |  | Shares |  |  | Par Value |  |  | Shares |  |  | Par Value |  |  | Capital |  |  | Shares |  |  | Cost |  |  | Income (Loss) |  |  | Earnings |  |  | Total |
Balance at June 30, 2023 |  |  | 13,866,999 |  |  | $ | 347 |  |  |  | 2,068,549 |  |  | $ | 52 |  |  | $ | 16,442 |  |  |  | 1,370,325 |  |  | $ | (3,740 | ) |  | $ | 1,348 |  |  | $ | 37,572 |  |  | $ | 52,021 |
Impact of ASU 2016-13 adoption, net of tax (Note 1) |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | (183 | ) |  |  | (183 | )
Balance at June 30, 2023 (as adjusted for change in accounting principle) |  |  | 13,866,999 |  |  | $ | 347 |  |  |  | 2,068,549 |  |  | $ | 52 |  |  | $ | 16,442 |  |  |  | 1,370,325 |  |  | $ | (3,740 | ) |  | $ | 1,348 |  |  | $ | 37,389 |  |  | $ | 51,838 |
Repurchases of shares of Common Stock (class A), including excise tax |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 198,213 |  |  |  | (617 | ) |  |  | - |  |  |  | - |  |  |  | (617 | )
Issuance of stock under ESPP of shares of Common Stock (class A) |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 2 |  |  |  | (5,494 | ) |  |  | 15 |  |  |  | - |  |  |  | - |  |  |  | 17 |
Dividends declared |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | (322 | ) |  |  | (322 | )
Other comprehensive income (loss), net of tax |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | (214 | ) |  |  | - |  |  |  | (214 | )
Net income (loss) |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | (176 | ) |  |  | (176 | )
Balance at September 30, 2023 |  |  | 13,866,999 |  |  | $ | 347 |  |  |  | 2,068,549 |  |  | $ | 52 |  |  | $ | 16,444 |  |  |  | 1,563,044 |  |  | $ | (4,342 | ) |  | $ | 1,134 |  |  | $ | 36,891 |  |  | $ | 50,526 |
Repurchases of shares of Common Stock (class A) |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 196,295 |  |  |  | (566 | ) |  |  | - |  |  |  | - |  |  |  | (566 | )
Issuance of stock under ESPP of shares of Common Stock (class A) |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | (6,100 | ) |  |  | 17 |  |  |  | - |  |  |  | - |  |  |  | 17 |
Dividends declared |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | (320 | ) |  |  | (320 | )
Other comprehensive income (loss), net of tax |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | (171 | ) |  |  | - |  |  |  | (171 | )
Net income (loss) |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 1,229 |  |  |  | 1,229 |
Balance at December 31, 2023 |  |  | 13,866,999 |  |  | $ | 347 |  |  |  | 2,068,549 |  |  | $ | 52 |  |  | $ | 16,444 |  |  |  | 1,753,239 |  |  | $ | (4,891 | ) |  | $ | 963 |  |  | $ | 37,800 |  |  | $ | 50,715 |
Repurchases of shares of Common Stock (class A) |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 211,282 |  |  |  | (582 | ) |  |  | - |  |  |  | - |  |  |  | (582 | )
Issuance of stock under ESPP of shares of Common Stock (class A) |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | (6,259 | ) |  |  | 17 |  |  |  | - |  |  |  | - |  |  |  | 17 |
Dividends declared |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | (312 | ) |  |  | (312 | )
Other comprehensive income (loss), net of tax |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | (132 | ) |  |  | - |  |  |  | (132 | )
Net income (loss) |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | (35 | ) |  |  | (35 | )
Balance at March 31, 2024 |  |  | 13,866,999 |  |  | $ | 347 |  |  |  | 2,068,549 |  |  | $ | 52 |  |  | $ | 16,444 |  |  |  | 1,958,262 |  |  | $ | (5,456 | ) |  | $ | 831 |  |  | $ | 37,453 |  |  | $ | 49,671 |

The accompanying notes are an integral part of these Consolidated Financial Statements.

Page 5

Table of Contents

U.S. GLOBAL INVESTORS, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

|  | Nine Months Ended March 31, |
(dollars in thousands) |  | 2025 |  |  | 2024 |
Cash Flows from Operating Activities: |  |  |  |  |  |  |  |
Net income (loss) |  | $ | (153 | ) |  | $ | 1,018 |
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: |  |  |  |  |  |  |  |
Depreciation, amortization and accretion |  |  | (100 | ) |  |  | (103 | )
Net realized (gains) losses on securities |  |  | (507 | ) |  |  | 5,928 |
Unrealized (gains) losses on securities |  |  | 219 |  |  |  | (5,594 | )
Provision for deferred taxes |  |  | 44 |  |  |  | 282 |
Reserve for uncertain tax positions |  |  | 53 |  |  |  | 53 |
Share-based compensation expense |  |  | 68 |  |  |  | - |
Allowance for credit losses |  |  | (61 | ) |  |  | (75 | )
Changes in operating assets and liabilities: |  |  |  |  |  |  |  |
Accounts and other receivables |  |  | 81 |  |  |  | 45 |
Prepaid expenses and other assets |  |  | (127 | ) |  |  | (97 | )
Accounts payable and other accrued liabilities |  |  | (325 | ) |  |  | (604 | )
Total adjustments |  |  | (655 | ) |  |  | (165 | )
Net cash provided by (used in) operating activities |  |  | (808 | ) |  |  | 853 |
Cash Flows from Investing Activities: |  |  |  |  |  |  |  |
Purchase of property and equipment |  |  | (6 | ) |  |  | (179 | )
Purchase of trading securities at fair value, non-current |  |  | (118 | ) |  |  | (219 | )
Proceeds on sale of trading securities at fair value, current |  |  | - |  |  |  | 1,600 |
Proceeds on sale of trading securities at fair value, non-current |  |  | - |  |  |  | 179 |
Proceeds from principal paydowns of available-for-sale debt securities at fair value |  |  | 2,250 |  |  |  | 2,250 |
Return of capital on other investments |  |  | - |  |  |  | 259 |
Net cash provided by (used in) investing activities |  |  | 2,126 |  |  |  | 3,890 |
Cash Flows from Financing Activities: |  |  |  |  |  |  |  |
Principal payments on financing lease |  |  | (24 | ) |  |  | (22 | )
Issuance of common stock |  |  | 55 |  |  |  | 51 |
Repurchases of common stock |  |  | (1,574 | ) |  |  | (1,748 | )
Dividends paid |  |  | (912 | ) |  |  | (965 | )
Net cash provided by (used in) financing activities |  |  | (2,455 | ) |  |  | (2,684 | )
Net increase (decrease) in cash, cash equivalents, and restricted cash |  |  | (1,137 | ) |  |  | 2,059 |
Beginning cash, cash equivalents, and restricted cash |  |  | 28,399 |  |  |  | 26,401 |
Ending cash, cash equivalents, and restricted cash |  | $ | 27,262 |  |  | $ | 28,460 |
Supplemental Disclosures of Non-Cash Investing and Financing Activities |  |  |  |  |  |  |  |
Dividends declared but not paid |  | $ | 300 |  |  | $ | 317 |
Excise tax liability accrued on stock repurchases |  | $ | 15 |  |  | $ | 17 |
Unsettled class A common stock repurchases |  | $ | 1 |  |  | $ | 11 |
Supplemental Disclosures of Cash Flow Information |  |  |  |  |  |  |  |
Cash paid for income taxes |  | $ | 128 |  |  | $ | 250 |
Cash paid for interest |  | $ | 1 |  |  | $ | - |

The accompanying notes are an integral part of these Consolidated Financial Statements.

Page 6

Table of Contents

U.S. GLOBAL INVESTORS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

NOTE 1. BASIS OF PRESENTATION AND CONSOLIDATION

U.S. Global Investors, Inc. (the “Company” or “U.S. Global”) has prepared the Consolidated Financial Statements in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and the rules and regulations of the United States Securities and Exchange Commission (“SEC”) that permit reduced disclosure for interim periods. The financial information included herein reflects all adjustments (consisting solely of normal recurring adjustments), which are, in management’s opinion, necessary for a fair presentation of results for the interim periods presented. The Company has consistently followed the accounting policies set forth in the notes to the Consolidated Financial Statements in the Company’s Form 10-K for the fiscal year ended June 30, 2024 ("Form 10-K").

The Consolidated Financial Statements include the accounts of the Company and its wholly owned subsidiaries, U.S. Global Investors (Bermuda) Limited, U.S. Global Investors (Canada) Limited (“USCAN”), and U.S. Global Indices, LLC.

There are two primary consolidation models in U.S. GAAP, the variable interest entity (“VIE”) and voting interest entity models. The Company’s evaluation for consolidation includes whether entities in which it has an interest or from which it receives fees are VIEs and whether the Company is the primary beneficiary of any VIEs identified in its analysis. A VIE is an entity in which either (a) the equity investment at risk is not sufficient to permit the entity to finance its own activities without additional financial support or (b) the group of holders of the equity investment at risk lack certain characteristics of a controlling financial interest. The primary beneficiary is the entity that has the obligation to absorb a majority of the expected losses or the right to receive the majority of the residual returns and consolidates the VIE on the basis of having a controlling financial interest.

The Company has variable interests in certain funds it advises, including specific funds within U.S. Global Investors Funds (“USGIF” or the “Funds”) and certain U.S Global exchange-traded fund (ETF) clients. However, is not deemed to be the primary beneficiary of these funds. The Company’s interests in these VIEs consist of the Company’s direct ownership therein and any fees earned but uncollected. See further information about these funds in Notes 2 and 3. In the ordinary course of business, the Company may choose to waive certain fees or assume operating expenses of the funds it advises for competitive, regulatory or contractual reasons (see Note 3 for information regarding fee waivers). The Company has not provided financial support to any of these entities outside the ordinary course of business. The Company’s risk of loss with respect to these VIEs is limited to the carrying value of its investments in, and fees receivable from, the entities. The Company is not deemed to be the primary beneficiary because it does not have the obligation to absorb a majority of the expected losses or the right to receive the majority of the residual returns. The Company does not consolidate these VIEs because it is not the primary beneficiary. The Company’s total exposure to unconsolidated VIEs, consisting of the carrying value of investment securities and receivables for fees, was $11.0 million at March 31, 2025, and $10.5 million at June 30, 2024.

The carrying amount of assets and liabilities recognized in the Consolidated Balance Sheets related to the Company's interests in these non-consolidated VIEs were as follows:

|  | Carrying Value and Maximum Exposure to Loss |
(dollars in thousands) |  | March 31, 2025 |  |  | June 30, 2024 |
Investments in trading securities at fair value, current |  | $ | 9,692 |  |  | $ | 9,644 |
Investments in trading securities at fair value, non-current |  |  | 837 |  |  |  | 806 |
Other receivables |  |  | 483 |  |  |  | 28 |
Total VIE assets, maximum exposure to loss |  | $ | 11,012 |  |  | $ | 10,478 |

Since the Company is not the primary beneficiary of the above funds it advises, the Company evaluated if it should consolidate under the voting interest entity model. Under the voting interest model, for legal entities other than partnerships, the usual condition for control is ownership, directly or indirectly, of more than 50 percent of the outstanding voting shares over an entity. The Company does not have control of any of the above funds it advises; therefore, the Company does not consolidate any of these funds.

All significant intercompany balances and transactions have been eliminated in consolidation. Certain amounts have been reclassified for comparative purposes. Due to rounding, the year-to-date amount may not be the exact sum of the quarterly amounts. The results of operations for the interim periods disclosed herein are not necessarily indicative of the results the Company may expect for the fiscal year ending June 30, 2025 (“fiscal 2025”).

The unaudited interim financial information in these Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements contained in the Company’s annual report on Form 10-K; interim disclosures generally do not repeat those in the annual statements.

Use of Estimates

Preparation of the Consolidated Financial Statements in accordance with GAAP requires management to make estimates and assumptions that affect amounts reported in the Consolidated Financial Statements and accompanying notes. Actual results may materially differ from those estimates.

Recent Accounting Pronouncements

In June 2016, the Financial Accounting Standards Board ("FASB") issued ASU 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, and has subsequently issued several amendments (collectively, “ASU 2016-13”). ASU 2016-13 adds to U.S. GAAP an impairment model (known as the current expected credit loss model, or "CECL") that is based on expected losses rather than incurred losses for most financial assets and certain other instruments. Under the new guidance, an entity recognizes as an allowance its estimate of expected credit losses. It also modifies the impairment model for available-for-sale debt securities; the concept of "other-than-temporary" impairment was replaced by a determination of whether any impairment is a result of a credit loss or other factors. To adopt the standard, entities are required to make a cumulative-effect adjustment to beginning retained earnings as of the beginning of the fiscal year in which the guidance is effective. The Company adopted the standard using the modified-retrospective approach for all financial assets measured at amortized cost on July 1, 2023, and recognized an initial allowance for credit losses of $232,000 for one held-to-maturity debt security. The cumulative-effect adjustment to beginning retained earnings, net of the related tax effect, was a decrease of $183,000.

Page 7

Table of Contents

In June 2022, the FASB issued ASU 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions (“ASU 2022-03”) to clarify the guidance in Topic 820, Fair Value Measurement, when measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security, and to introduce new disclosure requirements for equity securities subject to contractual sale restrictions that are measured at fair value. The standard became effective for the Company on July 1, 2024. The adoption of the standard did not have a material impact on the Company's Consolidated Financial Statements.

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (“ASU 2023-07”), which enhances the disclosures required for reportable segments in annual and interim consolidated financial statements, including additional, more detailed information about a reportable segment’s expenses. ASU 2023-07 is to be applied on a retrospective basis and is effective for the Company's fiscal 2025 annual Consolidated Financial Statements and interim periods beginning in fiscal 2026. The Company is currently evaluating the impact of ASU 2023-07 on its Consolidated Financial Statement disclosures but does not expect it to have a material effect.

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (“ASU 2023-09”), which enhances the transparency and decision usefulness of income tax disclosures. ASU 2023-09 will be effective for fiscal years beginning after December 15, 2024. Early adoption is permitted for annual financial statements that have not yet been issued or made available for issuance. The Company is currently evaluating the impact of ASU 2023-09 on its Consolidated Financial Statement disclosures.

In November 2024, the FASB issued ASU 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses (“ASU 2024-03”), which requires public business entities to disclose specified information about certain costs and expenses. ASU 2024-03 will be effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods with annual reporting periods beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the impact of ASU 2024-03 on its Consolidated Financial Statement disclosures.

NOTE 2. INVESTMENTS

As of March 31, 2025, the Company held investments carried at fair value on a recurring basis of $13.3 million and a cost basis of $16.5 million. The fair value of these investments is approximately 27.3 percent of the Company’s total assets at March 31, 2025. In addition, the Company held other investments of approximately $1.7 million and held-to-maturity debt investments, net of allowance for credit losses, of $929,000.

The cost basis of investments is adjusted for amortization of premium or accretion of discount on debt securities held and the recharacterization of distributions from investments in partnerships.

Concentrations of Credit Risk

A significant portion of the Company’s investments carried at fair value on a recurring basis is investments in USGIF, which were $10.5 million as of March 31, 2025, and June 30, 2024, and investments in HIVE Digital Technologies Ltd. (“HIVE”), which were $2.3 million as of March 31, 2025, and $4.4 million as of June 30, 2024.

Fair Value Hierarchy

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The valuation techniques described below maximize the use of observable inputs and minimize the use of unobservable inputs in determining fair value.

The inputs used for measuring financial instruments at fair value are summarized in the three broad levels listed below:

Level 1 – Inputs represent unadjusted quoted prices for identical assets exchanged in active markets.

Level 2 – Inputs include directly or indirectly observable inputs (other than Level 1 inputs) such as quoted prices for similar assets exchanged in active or inactive markets; quoted prices for identical assets exchanged in inactive markets; other inputs that may be considered in fair value determinations of the assets, such as interest rates and yield curves; and inputs that are derived principally from or corroborated by observable market data by correlation or other means.

Level 3 – Inputs include unobservable inputs used in the measurement of assets. The Company is required to use its own assumptions regarding unobservable inputs because there is little, if any, market activity in the assets and it may be unable to corroborate the related observable inputs. Unobservable inputs require management to make certain projections and assumptions about the information that would be used by market participants in valuing assets.

The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the financial instrument. The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities. Because of the inherent uncertainties of valuation, the values reflected may materially differ from the values received upon actual sale of those investments.

The Company has established a Proprietary Valuation Committee (the “Committee”) to administer and oversee the Company’s valuation policies and procedures, which are approved by the Board of Directors, and to perform a periodic review of valuations provided by independent pricing services.

For actively traded securities, the Company values investments using the closing price of the securities on the exchange or market on which the securities principally trade. If the security is not traded on the last business day of the quarter, it is generally valued at the mean between the last bid and ask quotation. The fair value of a security that has a restriction greater than one year is based on the quoted price for an otherwise identical unrestricted instrument that trades in a public market, adjusted for the estimated effect of the restriction. Contractual restrictions on the sale of an equity security are not considered in measuring the security's fair value. Mutual funds, which include open- and closed-end funds and exchange-traded funds, are valued at net asset value or closing price, as applicable.

Page 8

Table of Contents

For common share purchase warrants not traded on an exchange, the estimated fair value is determined using the Black-Scholes option-pricing model. This sophisticated model utilizes a number of assumptions in arriving at its results, including the estimated life, the risk-free interest rate, and historical volatility of the underlying common stock. The Company may change the assumption of the risk-free interest rate and utilize the yield curve for instruments with similar characteristics, such as credit ratings and jurisdiction, or change the expected volatility. The effects of changing any of the assumptions or factors employed by the Black-Scholes model may result in a significantly different valuation.

Certain convertible debt securities not traded on an exchange are valued by an independent third party using a binomial lattice model based on factors such as yield, quality, maturity, coupon rate, type of issuance, individual trading characteristics of the underlying common shares and other market data. The model utilizes a number of assumptions in arriving at its results. The effects of changing any of the assumptions or factors utilized in the binomial lattice model, including expected volatility, credit adjusted discount rates, and discounts for lack of marketability, may result in a significantly different valuation for the securities.

For other securities included in the fair value hierarchy with unobservable inputs, the Committee considers a number of factors in determining a security’s fair value, including the security’s trading volume, market values of similar class issuances, investment personnel’s judgment regarding the market experience of the issuer, financial status of the issuer, the issuer’s management, and back testing, as appropriate. The fair values may differ from what may have been used had a broader market for these securities existed. The Committee reviews inputs and assumptions and reports material items to the Board of Directors. Securities which do not have readily determinable fair values are also periodically reviewed by the Committee.

The following tables summarize the major categories of investments with fair values adjusted on a recurring basis as of March 31, 2025, and June 30, 2024, and other investments with fair values adjusted on a nonrecurring basis, with fair values shown according to the fair value hierarchy.

|  | March 31, 2025 |
|  |  |  |  |  | Significant |  |  | Significant |  |  |  |  |
|  | Quoted |  |  | Other |  |  | Unobservable |  |  |  |  |
|  | Prices |  |  | Inputs |  |  | Inputs |  |  |  |  |
(dollars in thousands) |  | (Level 1) |  |  | (Level 2) |  |  | (Level 3) |  |  | Total |
Investments carried at fair value on a recurring basis: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Investments in trading securities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Equity securities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Equities - Domestic |  | $ | 15 |  |  | $ | - |  |  | $ | - |  |  | $ | 15 |
Equities - International |  |  | 309 |  |  |  | - |  |  |  | - |  |  |  | 309 |
Exchange Traded Funds - Global equity |  |  | 69 |  |  |  | - |  |  |  | - |  |  |  | 69 |
Mutual funds - Fixed income |  |  | 9,692 |  |  |  | - |  |  |  | - |  |  |  | 9,692 |
Mutual funds - Global equity |  |  | 768 |  |  |  | - |  |  |  | - |  |  |  | 768 |
Total equity securities |  |  | 10,853 |  |  |  | - |  |  |  | - |  |  |  | 10,853 |
Debt securities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Corporate debt securities |  |  | 150 |  |  |  | - |  |  |  | - |  |  |  | 150 |
Total investments in trading securities: |  |  | 11,003 |  |  |  | - |  |  |  | - |  |  |  | 11,003 |
Investments in available-for-sale debt securities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Corporate debt securities - Convertible debentures |  |  | - |  |  |  | - |  |  |  | 2,302 |  |  |  | 2,302 |
Total investments carried at fair value on a recurring basis: |  | $ | 11,003 |  |  | $ | - |  |  | $ | 2,302 |  |  | $ | 13,305 |
Investments carried at fair value on a nonrecurring basis: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Other investments (1) |  | $ | - |  |  | $ | - |  |  | $ | - |  |  | $ | - |

1. | Other investments include equity securities without readily determinable fair values that are adjusted as a result of the measurement alternative. There were no adjustments during the nine months ended March 31, 2025.

|  | June 30, 2024 |
|  |  |  |  |  | Significant |  |  | Significant |  |  |  |  |
|  | Quoted |  |  | Other |  |  | Unobservable |  |  |  |  |
|  | Prices |  |  | Inputs |  |  | Inputs |  |  |  |  |
(dollars in thousands) |  | (Level 1) |  |  | (Level 2) |  |  | (Level 3) |  |  | Total |
Investments carried at fair value on a recurring basis: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Investments in trading securities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Equity securities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Equities - International |  | $ | 435 |  |  | $ | - |  |  | $ | - |  |  | $ | 435 |
Mutual funds - Fixed income |  |  | 9,644 |  |  |  | - |  |  |  | - |  |  |  | 9,644 |
Mutual funds - Global equity |  |  | 806 |  |  |  | - |  |  |  | - |  |  |  | 806 |
Total equity securities |  |  | 10,885 |  |  |  | - |  |  |  | - |  |  |  | 10,885 |
Debt securities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Corporate debt securities |  |  | 208 |  |  |  | - |  |  |  | - |  |  |  | 208 |
Total investments in trading securities: |  |  | 11,093 |  |  |  | - |  |  |  | - |  |  |  | 11,093 |
Investments in available-for-sale debt securities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Corporate debt securities - Convertible debentures |  |  | - |  |  |  | - |  |  |  | 4,414 |  |  |  | 4,414 |
Total investments carried at fair value on a recurring basis: |  | $ | 11,093 |  |  | $ | - |  |  | $ | 4,414 |  |  | $ | 15,507 |
Investments carried at fair value on a nonrecurring basis: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Other investments (1) |  | $ | - |  |  | $ | - |  |  | $ | 600 |  |  | $ | 600 |

1. | Other investments include equity securities without readily determinable fair values that were adjusted as a result of the measurement alternative on dates during the fiscal year ended June 30, 2024. These securities are classified as level 3 due to the infrequency of the observable price changes and/or restrictions on the shares.

Page 9

Table of Contents

The Company purchased common shares of HIVE, a company headquartered in the United States with cryptocurrency mining facilities in Iceland, Sweden, and Canada, at a cost of $31,000 in January 2025. The investment has a fair value of $15,000 and the security is classified as Level 1 in the preceding table as of March 31, 2025. The common shares represent ownership in HIVE of less than 0.1 percent as of March 31, 2025. Frank Holmes serves on the board as executive chairman of HIVE and held shares, options, and restricted stock units at March 31, 2025. From August 2018 through January 2023, Mr. Holmes was Interim CEO of HIVE.

The security classified as Level 3 and carried at fair value on a recurring basis in the preceding tables is an investment in convertible debentures of HIVE. The Company purchased convertible securities for $15.0 million in January 2021. The convertible securities were comprised of 8.0% interest-bearing unsecured convertible debentures, payable in quarterly installments with a final maturity in January 2026, and 5 million common share purchase warrants in the capital of HIVE. Under the original terms, the principal amount of each debenture was convertible into common shares in the capital of HIVE at a conversion rate of $2.34, and each whole warrant, which expired in January 2024, entitled the Company to acquire one common share at a price of $3.00 (Canadian). Under the current terms, which reflect a reverse stock split, the principal amount of each debenture is convertible into common shares in the capital of HIVE at a conversion rate of $11.70. The convertible securities did not represent ownership in HIVE as of March 31, 2025, or June 30, 2024. The convertible securities are subject to Canadian securities regulations.

There has been significant volatility in the market price of HIVE, which has materially impacted the value of the investments included on the Consolidated Balance Sheets, unrealized gain (loss) recognized in net investment income (loss), and unrealized gain (loss) recognized in other comprehensive income (loss). Cryptocurrency markets and related securities have been, and are expected to continue to be, volatile.

The Company recorded the debentures at the estimated fair value of $16.0 million on purchase date, and an unrealized gain of $6.9 million was recognized in other comprehensive income (loss), which will be realized in net investment income (loss) ratably using the effective interest method until maturity, conversion, or other disposition. The fair value of the debentures was $2.3 million and $4.4 million at March 31, 2025, and June 30, 2024, respectively. The remaining principal amount was $2.3 million as of March 31, 2025.

The Company utilizes an independent third-party to estimate the fair value of the HIVE convertible debentures and currently considers the fair value measurements to contain Level 3 inputs. The following table is a reconciliation of investments recorded at fair value for which unobservable inputs (Level 3) were used in determining fair value as of March 31, 2025.

Changes in Level 3 Assets Measured at Fair Value on a Recurring Basis

|  | Nine Months Ended March 31, 2025 |
|  | Investments in |
(dollars in thousands) |  | debt securities |
Beginning Balance |  | $ | 4,414 |
Principal maturities |  |  | (2,250 | )
Amortization of day one premium |  |  | (77 | )
Accretion of bifurcation discount |  |  | 226 |
Total gains or losses included in: |  |  |  |
Net Investment Income (Loss) |  |  | 495 |
Other Comprehensive Income (Loss) |  |  | (506 | )
Ending Balance |  | $ | 2,302 |

The following is quantitative information as of March 31, 2025, and June 30, 2024, with respect to the securities measured and carried at fair value on a recurring basis with the use of significant unobservable inputs (Level 3).

|  | March 31, 2025 |
(dollars in thousands) |  | Fair Value |  | Principal Valuation Techniques |  | Unobservable Inputs |
Investments in available-for-sale debt securities: |  |  |  |  |  |  |  |  |  |  |
Corporate debt securities - Convertible debentures |  | $ | 2,302 |  | Binomial lattice model |  | Volatility |  |  | 90.0 | %
|  |  |  |  |  |  | Credit Spread |  |  | 7.4 | %
|  |  |  |  |  |  | Risk-Free Rate |  |  | 2.5 | %

|  | June 30, 2024 |
(dollars in thousands) |  | Fair Value |  | Principal Valuation Techniques |  | Unobservable Inputs |
Investments in available-for-sale debt securities: |  |  |  |  |  |  |  |  |  |  |
Corporate debt securities - convertible debentures |  | $ | 4,414 |  | Binomial lattice model |  | Volatility |  |  | 95.0 | %
|  |  |  |  |  |  | Credit Spread |  |  | 8.2 | %
|  |  |  |  |  |  | Risk-Free Rate |  |  | 4.1 | %

Page 10

Table of Contents

Investments in Trading Securities at Fair Value

Investments in trading securities with readily determinable fair values are carried at fair value, and changes in unrealized gains or losses are reported in the current period's earnings. The following details the components of the Company’s trading securities carried at fair value as of March 31, 2025, and June 30, 2024.

|  | March 31, 2025 |
(dollars in thousands) |  | Cost |  |  | Unrealized Gains (Losses) |  |  | Fair Value |
Trading securities at fair value |  |  |  |  |  |  |  |  |  |  |  |
Equity securities: |  |  |  |  |  |  |  |  |  |  |  |
Equities - Domestic |  | $ | 77 |  |  | $ | (62 | ) |  | $ | 15 |
Equities - International |  |  | 761 |  |  |  | (452 | ) |  |  | 309 |
Exchange Traded Funds - Global equity |  |  | 86 |  |  |  | (17 | ) |  |  | 69 |
Mutual funds - Fixed income |  |  | 9,870 |  |  |  | (178 | ) |  |  | 9,692 |
Mutual funds - Global equity |  |  | 929 |  |  |  | (161 | ) |  |  | 768 |
Total equity securities at fair value |  |  | 11,723 |  |  |  | (870 | ) |  |  | 10,853 |
Debt securities: |  |  |  |  |  |  |  |  |  |  |  |
Corporate debt securities |  |  | 215 |  |  |  | (65 | ) |  |  | 150 |
Total trading securities at fair value |  | $ | 11,938 |  |  | $ | (935 | ) |  | $ | 11,003 |

|  | June 30, 2024 |
(dollars in thousands) |  | Cost |  |  | Unrealized Gains (Losses) |  |  | Fair Value |
Trading securities at fair value |  |  |  |  |  |  |  |  |  |  |  |
Equity securities: |  |  |  |  |  |  |  |  |  |  |  |
Equities - Domestic |  | $ | 45 |  |  | $ | (45 | ) |  | $ | - |
Equities - International |  |  | 762 |  |  |  | (327 | ) |  |  | 435 |
Mutual funds - Fixed income |  |  | 9,869 |  |  |  | (225 | ) |  |  | 9,644 |
Mutual funds - Global equity |  |  | 929 |  |  |  | (123 | ) |  |  | 806 |
Total equity securities at fair value |  |  | 11,605 |  |  |  | (720 | ) |  |  | 10,885 |
Debt securities: |  |  |  |  |  |  |  |  |  |  |  |
Corporate debt securities |  |  | 215 |  |  |  | (7 | ) |  |  | 208 |
Total trading securities at fair value |  | $ | 11,820 |  |  | $ | (727 | ) |  | $ | 11,093 |

Debt Investments

Investments in debt securities are classified on the acquisition dates and at each balance sheet date. Securities classified as held-to-maturity are carried at amortized cost, net of allowance for credit losses, reflecting the ability and intent to hold the securities to maturity. Debt securities classified as trading are acquired with the intent to sell in the near term and are carried at fair value with changes reported in earnings. All other debt securities are classified as available-for-sale and are carried at fair value.

Investment gains and losses on available-for-sale debt securities are recorded when the securities are sold, as determined on a specific identification basis, and recognized in current period earnings. Changes in unrealized gains on available-for-sale debt securities are reported net of tax in accumulated other comprehensive income (loss). For debt securities in an unrealized loss position, a loss in earnings is recognized for the excess of amortized cost over fair value if the Company intends to sell before the price recovers. Otherwise, the Company evaluates as of the balance sheet date whether the unrealized losses are attributable to credit losses or other factors. The severity of the decline in value, creditworthiness of the issuer and other relevant factors are considered. The portion of unrealized loss the Company believes is related to a credit loss is recognized in earnings, and the portion of unrealized loss the Company believes is not related to a credit loss is recognized in other comprehensive income (loss).

Certain derivatives embedded in other financial instruments, such as the conversion option in a convertible bond, are reported at fair value, and changes in fair value are recorded through earnings within net investment income (loss). The host contract continues to be accounted for in accordance with the appropriate accounting standard. The embedded derivative and the related host contract represent one legal contract and are combined on the Consolidated Balance Sheets and the tables that follow. The Company held one financial instrument classified as available-for-sale containing an embedded derivative, which represents an investment in HIVE, at March 31, 2025, and June 30, 2024. As of March 31, 2025, the unrealized loss position in the available-for-sale security was related to changes in the fair value of the embedded derivatives and not the result of credit losses; therefore, an allowance for credit losses was not recorded for the embedded derivatives.

Page 11

Table of Contents

The following details the components of the Company’s available-for-sale debt investments as of March 31, 2025, and June 30, 2024.

|  | March 31, 2025 |
(dollars in thousands) |  | Amortized Cost |  |  | Unrealized Gains in Other Comprehensive Income (Loss) |  |  | Unrealized Losses in Other Comprehensive Income (Loss) |  |  | Unrealized Losses in Net Investment Income (Loss) (1) |  |  | Fair Value |  |  | Allowance for Credit Losses |
Available-for-sale debt securities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Corporate debt securities - Convertible debentures |  | $ | 4,611 |  |  | $ | 233 |  |  | $ | - |  |  | $ | (2,542 | ) |  | $ | 2,302 |  |  | $ | - |

|  | June 30, 2024 |
(dollars in thousands) |  | Amortized Cost |  |  | Unrealized Gains in Other Comprehensive Income (Loss) |  |  | Unrealized Losses in Other Comprehensive Income (Loss) |  |  | Unrealized Losses in Net Investment Income (Loss) (1) |  |  | Fair Value |  |  | Allowance for Credit Losses |
Available-for-sale debt securities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Corporate debt securities - Convertible debentures |  | $ | 6,204 |  |  | $ | 740 |  |  | $ | - |  |  | $ | (2,530 | ) |  | $ | 4,414 |  |  | $ | - |

1. | Represents changes in unrealized gains and losses related to embedded derivatives included within net investment income (loss) on the Consolidated Statements of Operations.

The following table summarizes the fair values of embedded derivatives on the Consolidated Balance Sheets, categorized by risk exposure, at March 31, 2025, and June 30, 2024.

|  | March 31, 2025 |  |  | June 30, 2024 |
|  | Other Assets |  |  | Other Assets |
|  | Investments in |  |  | Investments in |
|  | available-for-sale |  |  | available-for-sale |
(dollars in thousands) |  | debt securities |  |  | debt securities |
Embedded Derivatives: |  |  |  |  |  |  |  |
Equity price risk exposure |  | $ | - |  |  | $ | 12 |

The following table presents the effect of embedded derivatives on the Consolidated Statements of Operations, categorized by risk exposure, for the three and nine months ended March 31, 2025, and 2024.

|  | Nine Months Ended |  |  | Three Months Ended |
|  | March 31, |  |  | March 31, |
|  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
|  | Other Income (Loss) |  |  | Other Income (Loss) |  |  | Other Income (Loss) |  |  | Other Income (Loss) |
(dollars in thousands) |  | Net Investment Income (Loss) |  |  | Net Investment Income (Loss) |  |  | Net Investment Income (Loss) |  |  | Net Investment Income (Loss) |
Embedded Derivatives: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Equity price risk exposure |  | $ | (12 | ) |  | $ | (85 | ) |  | $ | (1 | ) |  | $ | (22 | )

At March 31, 2025, and June 30, 2024, the Company held one debt security classified as held-to-maturity. The following details are the components of the Company’s held-to-maturity debt investments as of March 31, 2025, and June 30, 2024.

|  | March 31, 2025 |
(dollars in thousands) |  | Amortized Cost |  |  | Allowance for Credit Losses |  |  | Net Carrying Amount |  |  | Gross Unrecognized Holding Gains |  |  | Gross Unrecognized Holding Losses |  |  | Fair Value |
Held-to-maturity debt securities(1): |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Corporate debt securities |  | $ | 1,000 |  |  | $ | (71 | ) |  | $ | 929 |  |  | $ | - |  |  | $ | - |  |  | $ | 929 |

|  | June 30, 2024 |
(dollars in thousands) |  | Amortized Cost |  |  | Allowance for Credit Losses |  |  | Net Carrying Amount |  |  | Gross Unrecognized Holding Gains |  |  | Gross Unrecognized Holding Losses |  |  | Fair Value |
Held-to-maturity debt securities(1): |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Corporate debt securities |  | $ | 1,000 |  |  | $ | (132 | ) |  | $ | 868 |  |  | $ | - |  |  | $ | - |  |  | $ | 868 |

1. | Held-to-maturity debt investments are carried at amortized cost, net of allowance for credit losses, and the fair value is classified as Level 2 according to the fair value hierarchy.

Page 12

Table of Contents

On July 1, 2023, the Company adopted ASU 2016-13, which replaced the incurred loss methodology for determining our allowance for credit losses and related provision for credit losses with an expected loss methodology that is referred to as the Current Expected Credit Losses ("CECL") model. CECL is a significant accounting estimate used in the preparation of the Company's Consolidated Financial Statements. Upon adoption of ASU 2016-13, the Company replaced the incurred loss impairment model that recognizes losses when it becomes probable that a credit loss will be incurred, with a requirement to recognize lifetime expected credit losses immediately when a financial asset is originated or purchased. CECL is a valuation account that is deducted from the amortized cost basis of held-to-maturity debt securities to present the net amount expected to be collected on the securities. Held-to-maturity debt securities, or portions thereof, are charged against the allowance when they are deemed uncollectible. Arriving at an appropriate level of credit losses involves a high degree of judgment. While management uses available information to recognize losses, changing economic conditions and the economic prospects of the issuers may necessitate future additions or reductions to the allowance.

The Company monitors the credit quality of debt securities through credit ratings from various rating agencies. Credit ratings express opinions about the credit quality of a security and are utilized by the Company to make informed decisions. Investment grade securities are rated BBB-/Baa3 or higher and generally considered by the rating agencies and market participants to be of low credit risk. Conversely, securities rated below investment grade are considered to have distinctively higher credit risk than investment grade securities. For securities without credit ratings, the Company utilizes other financial information indicating the financial health of the underlying organization. As of March 31, 2025, and June 30, 2024, the held-to-maturity debt investment held by the Company did not have a credit rating.

Since the held-to-maturity debt security does not have a credit rating, management has determined that the discounted cash flow method provides the best basis for its assessment and determination of expected credit losses. The Company has elected to reflect the change in the allowance solely attributable to the passage of time in interest income. Changes attributable to the passage of time are those solely due to changes in the present value of the expected cash flows as the instrument approaches maturity rather than expectations of cash flow timing or amounts. The change in allowance for credit losses attributable to the passage of time, included as an increase in interest income within net investment income (loss) on the Consolidated Statements of Operations, was $3,000 and $61,000 for the three and nine months ended March 31, 2025, respectively, and $20,000 and $75,000 for the three and nine months ended March 31, 2024, respectively.

The following table presents the activity in the allowance for credit losses for the held-to-maturity debt investment for the nine months ended March 31, 2025, and 2024. There was no allowance at June 30, 2023.

|  | Nine Months Ended |
|  | March 31, |
(dollars in thousands) |  | 2025 |  |  | 2024 |
Beginning Balance |  | $ | 132 |  |  | $ | - |
Impact of ASU 2016-13 adoption |  |  | - |  |  |  | 232 |
Provision for credit losses - reversal (1) |  |  | (61 | ) |  |  | (75 | )
Ending Balance |  | $ | 71 |  |  | $ | 157 |

1. | Represents the change in present value attributable to the passage of time included in interest income.

The following summarizes the net carrying amount and estimated fair value of available-for-sale and held-to-maturity debt securities at March 31, 2025, by contractual maturity dates. Actual maturities may differ from final contractual maturities due to principal repayment installments or prepayment rights held by issuers.

|  | March 31, 2025 |
|  | Available-for-sale |  |  | Held-to-maturity |
|  | debt securities |  |  | debt securities |
|  | Convertible |  |  | Due after one year |
(dollars in thousands) |  | debentures (1) |  |  | through five years |
Amortized Cost |  | $ | 4,611 |  |  | $ | 1,000 |
Fair Value |  | $ | 2,302 |  |  | $ | 929 |

1. | Principal payments of $750,000 are due quarterly with a final maturity date in January 2026.

As of March 31, 2025, none of the Company's investments in debt securities were delinquent or in a non-accrual status, and accrued interest receivable of $25,000 and $13,000 is included in accounts and other receivables on the Consolidated Balance Sheets as of March 31, 2025, and June 30, 2024, respectively.

Other Investments

Other investments consist of equity investments in entities over which the Company is unable to exercise significant influence and which do not have readily determinable fair values. For these securities, the Company generally elects to value using the measurement alternative, under which such securities are measured at cost, less impairment, if any. If the Company identifies observable price changes for identical or similar securities of the same issuer, the equity security is measured at fair value as of the date the observable transaction occurred, with such changes recorded in net investment income (loss).

The carrying value of equity securities without readily determinable fair values was approximately $1.7 million as of June 30, 2024. The following table presents the carrying value of equity securities without readily determinable fair values held as of March 31, 2025, and 2024, that are measured under the measurement alternative and the related adjustments recorded during the periods presented for those securities with observable price changes or impairments. These securities are included in the nonrecurring fair value hierarchy tables when applicable price changes are observable, or when impairments occur.

|  | Nine Months Ended |  |  | Three Months Ended |
|  | March 31, |  |  | March 31, |
(dollars in thousands) |  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
Other Investments |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Carrying value |  | $ | 1,687 |  |  | $ | 1,114 |  |  | $ | 1,687 |  |  | $ | 1,114 |
Upward carrying value changes |  | $ | - |  |  | $ | - |  |  | $ | - |  |  | $ | - |
Downward carrying value changes/impairment |  | $ | - |  |  | $ | (1,274 | ) |  | $ | - |  |  | $ | (499 | )

The period-end carrying values reflect cumulative purchases and sales in addition to upward and downward carrying value changes. The cumulative amount of upward adjustments to all equity securities without readily determinable fair values total $2.5 million since their respective acquisitions through March 31, 2025. The cumulative amount of impairments and other downward adjustments, which include return of capital distributions and observable price changes, to all equity securities without readily determinable fair values total $5.0 million since their respective acquisitions through March 31, 2025.

Page 13

Table of Contents

The Company has an investment in The Sonar Company (“Sonar”), a company headquartered in the United States, at a cost of $175,000. The investment had a carrying value of approximately $362,000 at March 31, 2025, and June 30, 2024. Roy D. Terracina, Director and Vice Chairman of the Board of Directors for U.S. Global, has served as the CEO of Sonar since July 2021, and the Company’s ownership of Sonar was approximately 2.8 percent as of March 31, 2025.

Net Investment Income (Loss)

Net investment income (loss) from the Company’s investments includes:

| ● | realized gains and losses on sales of securities;
| ● | realized gains and losses on principal payment proceeds;
| ● | unrealized gains and losses on securities at fair value;
| ● | impairments and observable price changes on equity investments without readily determinable fair values;
| ● | dividend and interest income; and
| ● | realized foreign currency gains and losses.

The following summarizes net investment income (loss) reflected in earnings for the periods presented.

|  | Nine Months Ended |  |  | Three Months Ended |
(dollars in thousands) |  | March 31, |  |  | March 31, |
Net Investment Income (Loss) |  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
Realized gains (losses) on equity securities |  | $ | - |  |  | $ | (6,834 | ) |  | $ | - |  |  | $ | (6,094 | )
Realized gains (losses) on debt securities |  |  | 507 |  |  |  | 906 |  |  |  | 134 |  |  |  | 267 |
Unrealized gains (losses) on equity securities |  |  | (149 | ) |  |  | 5,699 |  |  |  | (50 | ) |  |  | 5,863 |
Unrealized gains (losses) on debt securities |  |  | (58 | ) |  |  | (20 | ) |  |  | (9 | ) |  |  | (65 | )
Unrealized gains (losses) on embedded derivatives |  |  | (12 | ) |  |  | (85 | ) |  |  | (1 | ) |  |  | (22 | )
Unrealized gains (losses) on cash equivalents |  |  | 9 |  |  |  | (2 | ) |  |  | 9 |  |  |  | - |
Dividend and interest income |  |  | 1,715 |  |  |  | 1,781 |  |  |  | 466 |  |  |  | 595 |
Realized foreign currency gains (losses) |  |  | (193 | ) |  |  | (82 | ) |  |  | (1 | ) |  |  | (84 | )
Total Net Investment Income (Loss) |  | $ | 1,819 |  |  | $ | 1,363 |  |  | $ | 548 |  |  | $ | 460 |

Realized gains on debt securities reclassified from other comprehensive income (loss) related to the Company's investment in HIVE debentures were $134,000 and $507,000 for the three and nine months ended March 31, 2025, respectively, and $267,000 and $906,000 for the three and nine months ended March 31, 2024, respectively.

The unrealized gains and losses recognized during the three and nine months ended March 31, 2025, and 2024, on equity securities and debt securities classified as trading that were still held as of each respective date, are summarized as follows.

|  | Nine Months Ended |  |  | Three Months Ended |
|  | March 31, |  |  | March 31, |
(dollars in thousands) |  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
Equity securities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net gains and losses recognized during the period |  | $ | (149 | ) |  | $ | (1,135 | ) |  | $ | (50 | ) |  | $ | (231 | )
Less: Net gains and losses recognized during the period on securities sold during the period |  |  | - |  |  |  | (256 | ) |  |  | - |  |  |  | (3 | )
Unrealized gains and losses recognized during the reporting period on securities still held at the reporting date (1) |  | $ | (149 | ) |  | $ | (879 | ) |  | $ | (50 | ) |  | $ | (228 | )
Debt securities classified as trading: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net gains and losses recognized during the period |  | $ | (58 | ) |  | $ | (20 | ) |  | $ | (9 | ) |  | $ | (65 | )
Less: Net gains and losses recognized during the period on securities sold during the period |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Unrealized gains and losses recognized during the reporting period on securities still held at the reporting date |  | $ | (58 | ) |  | $ | (20 | ) |  | $ | (9 | ) |  | $ | (65 | )

1. | Includes net unrealized and realized losses of $240,000 and $1.0 million as a result of the measurement alternative for the three and nine months ended March 31, 2024, respectively. There were no amounts included as a result of the measurement alternative for the three and nine months ended March 31, 2025.

Net investment income (loss) can be volatile and vary depending on market fluctuations, the Company’s ability to participate in investment opportunities, and the timing of transactions. The Company expects that gains and losses will continue to fluctuate in the future.

Page 14

Table of Contents

NOTE 3. INVESTMENT MANAGEMENT AND OTHER FEES

The following table presents operating revenues disaggregated by performance obligation.

|  | Nine Months Ended |  |  | Three Months Ended |
|  | March 31, |  |  | March 31, |
(dollars in thousands) |  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
ETF advisory fees |  | $ | 5,251 |  |  | $ | 7,394 |  |  | $ | 1,657 |  |  | $ | 2,224 |
USGIF advisory fees |  |  | 1,378 |  |  |  | 1,408 |  |  |  | 484 |  |  |  | 443 |
USGIF performance fees received (paid) |  |  | (229 | ) |  |  | (344 | ) |  |  | (69 | ) |  |  | (101 | )
Total Advisory Fees |  |  | 6,400 |  |  |  | 8,458 |  |  |  | 2,072 |  |  |  | 2,566 |
USGIF administrative services fees |  |  | 92 |  |  |  | 86 |  |  |  | 31 |  |  |  | 27 |
Total Operating Revenue |  | $ | 6,492 |  |  | $ | 8,544 |  |  | $ | 2,103 |  |  | $ | 2,593 |

The Company serves as investment advisor to four U.S.-based exchange-traded fund (ETF) clients: U.S. Global Jets ETF (ticker JETS), U.S. Global GO GOLD and Precious Metal Miners ETF (ticker GOAU), U.S. Global Sea to Sky Cargo ETF (ticker SEA), and U.S. Global Technology and Aerospace & Defense ETF (ticker WAR). The Company receives a unitary management fee of 0.60 percent of average net assets and has agreed to bear all expenses of the U.S.-based ETFs, except the U.S. Global Sea to Sky Cargo ETF ("SEA"). The Company has agreed to contractually limit the expenses of SEA through April 2026. The aggregate fees waived, and expenses borne by the Company for SEA were $33,000 and $111,000 for the three and nine months ended March 31, 2025, respectively, and $37,000 and $115,000 for the three and nine months ended March 31, 2024, respectively. The Company also serves as an investment advisor to one European-based ETF, The Travel UCITS ETF (ticker TRIP). The U.S. Global Jets UCITS ETF merged into The Travel UCITS ETF in April 2024. The Company receives a unitary management fee of 0.69 percent of average net assets and has agreed to bear all expenses of the European-based ETF.

The Company serves as investment adviser to USGIF and receives advisory fees comprised of two components: a base management fee and a performance fee. The management fee is based on a specified percentage of net assets under management. The performance fee is a fulcrum fee that is adjusted upwards or downwards by 0.25 percent when there is a performance difference of 5 percent or more between a fund’s performance and that of its designated benchmark index over the prior rolling 12 months. This performance adjustment began to be phased out during the fourth quarter of fiscal 2024 and will cease during the fourth quarter of fiscal 2025. During the phase-out period, the adjustment for the performance fee can only be adjusted downward.

The Company has agreed to contractually limit the expenses of USGIF, except the U.S. Government Securities Ultra-Short Bond Fund, through April 2026. The Company has voluntarily waived or reduced its fees and/or agreed to pay expenses on the U.S. Government Securities Ultra-Short Bond Fund. This cap will continue on a voluntary basis at the Company’s discretion. The aggregate fees waived and expenses borne by the Company for USGIF were $211,000 and $743,000 for the three and nine months ended March 31, 2025, respectively, and $193,000 and $638,000 for the three and nine months ended March 31, 2024, respectively. Management cannot predict the impact of future waivers due to the number of variables and the range of potential outcomes.

The Company receives administrative service fees from USGIF based on an annual rate of 0.05 percent on the average daily net assets of each fund.

As of March 31, 2025, the Company had $665,000 in receivables from fund clients, of which $541,000 was from the ETFs and $124,000 was from USGIF. As of June 30, 2024, the Company had $772,000 in receivables from fund clients, of which $647,000 was from the ETFs and $125,000 was from USGIF. There was no allowance for credit losses related to receivables as of March 31, 2025, or June 30, 2024.

Page 15

Table of Contents

NOTE 4. RESTRICTED AND UNRESTRICTED CASH

The Company maintains its cash deposits with established commercial banks. At times, balances may exceed federally insured limits. We have not experienced any losses in such accounts and do not believe that we are exposed to any significant credit risk associated with our cash deposits. Restricted cash represents cash invested in a money market account as collateral for credit facilities that is not available for general corporate use.

A reconciliation of cash, cash equivalents, and restricted cash reported from the Consolidated Balance Sheets to the Consolidated Statements of Cash Flows is shown below.

(dollars in thousands) |  | March 31, 2025 |  |  | June 30, 2024 |
Cash and cash equivalents |  | $ | 26,262 |  |  | $ | 27,399 |
Restricted cash |  |  | 1,000 |  |  |  | 1,000 |
Total cash, cash equivalents, and restricted cash |  | $ | 27,262 |  |  | $ | 28,399 |

NOTE 5. LEASES

The Company has lease agreements for office equipment that expire in the fiscal year 2026. Lease expenses included in general and administrative expense on the Consolidated Statements of Operations totaled $25,000 and $75,000 for the three and nine months ended March 31, 2025, respectively, and $33,000 and $99,000 for the three and nine months ended March 31, 2024, respectively.

The following table presents the components of lease cost.

|  | Nine Months Ended |  |  | Three Months Ended |
|  | March 31, |  |  | March 31, |
(dollars in thousands) |  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
Finance lease cost: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Amortization of right-of-use assets |  | $ | 24 |  |  | $ | 23 |  |  | $ | 8 |  |  | $ | 7 |
Interest on lease liabilities |  |  | 1 |  |  |  | 2 |  |  |  | - |  |  |  | 1 |
Total finance lease cost |  |  | 25 |  |  |  | 25 |  |  |  | 8 |  |  |  | 8 |
Short-term lease cost |  |  | 51 |  |  |  | 76 |  |  |  | 17 |  |  |  | 26 |
Total lease cost |  | $ | 76 |  |  | $ | 101 |  |  | $ | 25 |  |  | $ | 34 |

Supplemental information related to the Company's leases follows.

|  | Nine Months Ended |  |  | Three Months Ended |
|  | March 31, |  |  | March 31, |
(dollars in thousands) |  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
Operating cash flows from financing leases included in lease liabilities |  | $ | 1 |  |  | $ | 2 |  |  | $ | - |  |  | $ | 1 |
Financing cash flows from financing leases included in lease liabilities |  | $ | 24 |  |  | $ | 22 |  |  | $ | 8 |  |  | $ | 7 |

Additional qualitative information concerning the Company’s leases follows.

|  | March 31, 2025 |  |  | June 30, 2024 |
Weighted-average remaining lease term - financing leases (years) |  |  | 0.50 |  |  |  | 1.25 |
Weighted-average discount rate - financing leases |  |  | 4.75 | % |  |  | 4.75 | %

The following table presents the maturities of lease liabilities as of March 31, 2025.

(dollars in thousands) |  |  |  |
Fiscal Year |  | Finance Leases |
2025 (excluding the nine months ended March 31, 2025) |  | $ | 9 |
2026 |  |  | 8 |
Total lease payments |  |  | 17 |
Less imputed interest |  |  | - |
Total |  | $ | 17 |

The Company is the lessor of certain areas of its owned office building under operating leases expiring in various months through fiscal year 2026. At the commencement of an operating lease, no income is recognized; subsequently, lease payments received are recognized on a straight-line basis. Lease income included in other income on the Consolidated Statements of Operations was $28,000 and $75,000 for the three and nine months ended March 31, 2025, respectively, and $23,000 and $78,000 for the three and nine months ended March 31, 2024, respectively. The cost of obtaining lessor contracts, which is included in other assets on the Consolidated Balance Sheets, was nil at March 31, 2025, and $2,000 at June 30, 2024.

The Company is also party to a lease agreement with HIVE, a related party, for certain areas of the Company’s office building. The terms of the lease were determined to be consistent with market rates.

Page 16

Table of Contents

The following is a summary analysis of annual undiscounted cash flows to be received on leases as of March 31, 2025.

(dollars in thousands) |  |  |  |
Fiscal Year |  | Operating Leases |
2025 (excluding the nine months ended March 31, 2025) |  | $ | 16 |
2026 |  |  | 45 |
Total lease payments |  | $ | 61 |

The Company may terminate the building leases with one hundred eighty days written notice if it sells the property. If the Company terminates the lease, the Company will pay the tenant a termination fee of the lesser of six months of the base monthly rent or the base monthly rent times the number of months remaining in the initial term.

NOTE 6. OTHER ACCRUED EXPENSES

Other accrued expenses consist of the following:

(dollars in thousands) |  | March 31, 2025 |  |  | June 30, 2024 |
Professional fees |  | $ | 485 |  |  | $ | 571 |
Vendors payable |  |  | 266 |  |  |  | 182 |
ETF operating and distribution expenses |  |  | 359 |  |  |  | 365 |
Other taxes payable |  |  | 56 |  |  |  | 79 |
Other accrued expenses |  | $ | 1,166 |  |  | $ | 1,197 |

As of March 31, 2025, and June 30, 2024, the Company had receivables from HIVE totaling $279,000 and $207,000, respectively, related to reimbursements for certain expenses. These amounts, reported within accounts and other receivables on the Consolidated Balance Sheets, include reimbursements for expenses presented in the table above, as well as additional reimbursable amounts not included in the table.

NOTE 7. DEBT

The Company has access to a $1.0 million credit facility for working capital purposes. The credit agreement requires the Company to maintain certain covenants; the Company has been in compliance with these covenants during the current fiscal year. The credit agreement expires on May 31, 2026, and the Company intends to renew it biennially. The credit facility is collateralized by approximately $1.0 million at March 31, 2025, included in restricted cash on the Consolidated Balance Sheets, held in deposit in a money market account at the financial institution that provided the credit facility. As of March 31, 2025, the credit facility remains unutilized by the Company.

NOTE 8. STOCKHOLDERS’ EQUITY

Payment of cash dividends is within the discretion of the Company’s Board of Directors and is dependent on earnings, operations, capital requirements, general financial condition of the Company, and general business conditions. The dividend rate per share was $0.0075 per month for fiscal year 2025 and through March 2025.

In March 2025, the Board authorized the continuance of the monthly dividend of $0.0075 per share from April through June 2025, at which time it will be considered for continuation by the Board.

The Company has a share repurchase program, approved by the Board of Directors, authorizing the Company to annually purchase up to $5.0 million of its outstanding common shares, as market and business conditions warrant, on the open market in compliance with Rule 10b-18 and Rule 10b5-1 of the Securities Exchange Act of 1934. The repurchase program has been in place since December 2012, and the Board of Directors has annually renewed the repurchase program each calendar year. The Company announced on February 25, 2022, that the Board of Directors of the Company approved an increase to the limit of its annual share buyback program from $2.75 million to $5.0 million. The Company announced on September 19, 2024, that the Board of Directors of the Company approved an update authorizing the Company to repurchase up to $5.0 million of its outstanding common shares between September 13, 2024, and December 31, 2024. The total amount of shares that may be repurchased under the program was $6.5 million in 2024 and is $5.0 million in 2025. The acquired shares may be used for corporate purposes, including shares issued to employees in the Company’s stock-based compensation programs. During the three and nine months ended March 31, 2025, the Company repurchased 187,987 and 622,605, respectively, of its class A shares using cash of $454,000 and $1.6 million, respectively. During the three and nine months ended March 31, 2024, the Company repurchased 211,282 and 605,790, respectively, of its class A shares using cash of $577,000 and $1.7 million, respectively.

The Inflation Reduction Act of 2022, which was enacted in August 2022, imposed a 1% excise tax on stock buybacks by publicly traded corporations, effective on January 1, 2023. Any excise tax incurred is recognized as part of the cost basis of the shares acquired in the Consolidated Statements of Shareholders' Equity. The impact of these provisions was $5,000 and $15,000 for the three and nine months ended March 31, 2025, respectively, and $5,000 and $17,000 for the three and nine months ended March 31, 2024, respectively. All amounts presented in this report related to the Company's share repurchases and the Company's share repurchase authorization exclude such excise taxes, to the extent applicable, unless otherwise indicated.

Page 17

Table of Contents

Stock Option Plans

The Company’s stock option plans allow for the granting of class A shares as either incentive or non-qualified stock options to employees and non-employee directors. The terms and conditions of these options, including exercise price, vesting schedule, and expiration, are determined by the Compensation Committee of the Board of Directors.

Under the 1989 Plan, there were 125,100 nonvested stock options outstanding as of March 31, 2025, with a weighted average exercise of $2.41. Additionally, there were 228,000 and 229,000 stock options outstanding and exercisable as of March 31, 2025, and March 31, 2024, respectively, with a weighted average exercise price of $6.05.

Under the 1997 Plan, there were 2,000 stock options outstanding and exercisable as of both March 31, 2025, and March 31, 2024, with a weighted average exercise price of $2.74.

Stock Option Activity

During the three months ended March 31, 2025, the Company granted 25,000 stock options with a weighted average grant date fair value of $0.99. These options are subject to a six-month vesting period. During the nine months ended March 31, 2025, the Company granted a total of 125,100 stock options with a weighted average grant date fair value of $1.06, also subject to a six-month vesting period. The fair value of these options was estimated using the Black-Scholes option pricing model.

No stock options were forfeited or exercised during the three months ended March 31, 2025. During the nine months ended March 31, 2025, 1,000 stock options were forfeited, and no stock options were exercised. For the three and nine months ended March 31, 2024, no stock options were granted, forfeited, or exercised.

Share-Based Compensation Expense

The Company measures share-based compensation expense at the grant date, based on the fair value of the awards. This expense is recognized ratably over the awards’ vesting period.

For the three and nine months ended March 31, 2025, the Company recognized share-based compensation expense of $58,000 and $68,000, respectively. As of March 31, 2025, the total unrecognized share-based compensation cost related to nonvested awards was $65,000, which is expected to be recognized over a weighted average period of 0.25 years.

For the three and nine months ended March 31, 2024, no share-based compensation expense was recognized. As of March 31, 2024, there were no unrecognized share-based compensation costs related to share-based awards under the plans.

NOTE 9. EARNINGS PER SHARE

The basic earnings per share (“EPS”) calculation excludes dilution and is computed by dividing net income by the weighted average number of common shares outstanding for the period. Diluted EPS reflects the potential dilution of EPS that could occur if options to issue common stock were exercised.

The following table sets forth the computation for basic and diluted EPS.

|  | Nine Months Ended |  |  | Three Months Ended |
|  | March 31, |  |  | March 31, |
(dollars in thousands, except per share data) |  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
Net Income (Loss) |  | $ | (153 | ) |  | $ | 1,018 |  |  | $ | (382 | ) |  | $ | (35 | )
Weighted average number of outstanding shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Basic |  |  | 13,414,873 |  |  |  | 14,278,691 |  |  |  | 13,023,636 |  |  |  | 14,077,042 |
Effect of dilutive securities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock options |  |  | 3,168 |  |  |  | 86 |  |  |  | 805 |  |  |  | - |
Diluted |  |  | 13,418,041 |  |  |  | 14,278,777 |  |  |  | 13,024,441 |  |  |  | 14,077,042 |
Earnings (Loss) Per Share |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Basic Net Income (Loss) per share |  | $ | (0.01 | ) |  | $ | 0.07 |  |  | $ | (0.03 | ) |  | $ | (0.00 | )
Diluted Net Income (Loss) per share |  | $ | (0.01 | ) |  | $ | 0.07 |  |  | $ | (0.03 | ) |  | $ | (0.00 | )

The diluted EPS calculation excludes the effect of stock options when their exercise prices exceed the average market price for the period, as their inclusion would be anti-dilutive. For the three and nine months ended March 31, 2025, employee stock options of 330,100 and 230,000, respectively, were excluded from diluted EPS. For the three and nine months ended March 31, 2024, employee stock options of 231,000 and 229,000, respectively, were excluded from diluted EPS.

During the three and nine months ended March 31, 2025, and 2024, the Company repurchased class A shares on the open market. Upon repurchase, these shares are classified as treasury shares and are deducted from outstanding shares in the earnings per share calculation.

Page 18

Table of Contents

NOTE 10. INCOME TAXES

The Company and its non-Canadian subsidiaries file a consolidated U.S. federal income tax return. USCAN files a separate tax return in Canada. Provisions for income taxes include deferred taxes for temporary differences in the bases of assets and liabilities for financial and tax purposes resulting from the use of the liability method of accounting for income taxes.

Income tax expense for the quarter is based upon the estimated annual ordinary income in each jurisdiction in which the Company operates. The tax effects of discrete items are recognized in the tax provision in the period they occur in accordance with U.S. GAAP. Due to various factors, such as the item’s significance in relation to total ordinary income and the rate of tax, discrete items in any quarter can materially impact the reported effective tax rate ("ETR"). The effective tax rate was (55.9) percent and 301.3 percent for the three and nine months ended March 31, 2025, respectively, and 187.5 percent and 30.5 percent for the three and nine months ended March 31, 2024, respectively.

A valuation allowance is provided when it is more likely than not that some portion of the deferred tax amount will not be realized. A valuation allowance of $41,000 was included at March 31, 2025. There was no valuation allowance included at June 30, 2024.

The Company maintains a reserve for uncertain tax positions for income tax matters. As of March 31, 2025, and June 30, 2024, the total reserve for uncertain tax positions, including interest and penalties, and net of federal benefits, was $838,000 and $785,000, respectively, which is included within long-term liabilities on the Consolidated Balance Sheets. The Company believes the reserve for uncertain tax positions, including interest and penalties, and net of federal benefits, of $838,000 adequately covers open tax years and uncertain tax positions up to and including March 31, 2025, for major taxing jurisdictions. As of March 31, 2025, the entire $838,000 of unrecognized tax benefits, if recognized, would impact the Company's effective income tax rate.

NOTE 11. ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)

The following table presents the change in accumulated other comprehensive income (loss) (“AOCI”) by component.

(dollars in thousands) |  | Unrealized gains (losses) on available-for-sale investments |
Nine Months Ended March 31, 2025 |  |  |  |
Balance at June 30, 2024 |  | $ | 584 |
Other comprehensive income (loss) before reclassifications |  |  | 1 |
Tax effect |  |  | - |
Amount reclassified from AOCI |  |  | (507 | )
Tax effect |  |  | 106 |
Net other comprehensive income (loss) |  |  | (400 | )
Balance at March 31, 2025 |  | $ | 184 |
Nine Months Ended March 31, 2024 |  |  |  |
Balance at June 30, 2023 |  | $ | 1,348 |
Other comprehensive income (loss) before reclassifications |  |  | 251 |
Tax effect |  |  | (52 | )
Amount reclassified from AOCI |  |  | (906 | )
Tax effect |  |  | 190 |
Net other comprehensive income (loss) |  |  | (517 | )
Balance at March 31, 2024 |  | $ | 831 |

Page 19

Table of Contents

NOTE 12. FINANCIAL INFORMATION BY BUSINESS SEGMENT

The Company operates principally in two business segments: providing investment management services to USGIF and ETF clients; and investing for its own account in an effort to add growth and value to its cash position. The following schedule details gross identifiable assets, total revenues, and income by business segment.

(dollars in thousands) |  | Investment Management Services |  |  | Corporate Investments |  |  | Consolidated |
Nine Months Ended March 31, 2025 |  |  |  |  |  |  |  |  |  |  |  |
Operating revenues |  | $ | 6,492 |  |  | $ | - |  |  | $ | 6,492 |
Net investment income (loss) |  | $ | - |  |  | $ | 1,819 |  |  | $ | 1,819 |
Other income (loss) |  | $ | 247 |  |  | $ | - |  |  | $ | 247 |
Income (loss) before income taxes |  | $ | (1,675 | ) |  | $ | 1,751 |  |  | $ | 76 |
Depreciation |  | $ | 50 |  |  | $ | - |  |  | $ | 50 |
Gross identifiable assets at March 31, 2025 |  | $ | 26,531 |  |  | $ | 20,325 |  |  | $ | 46,856 |
Deferred tax asset |  |  |  |  |  |  |  |  |  | $ | 1,902 |
Consolidated total assets at March 31, 2025 |  |  |  |  |  |  |  |  |  | $ | 48,758 |
Nine Months Ended March 31, 2024 |  |  |  |  |  |  |  |  |  |  |  |
Operating revenues |  | $ | 8,544 |  |  | $ | - |  |  | $ | 8,544 |
Net investment income (loss) |  | $ | - |  |  | $ | 1,363 |  |  | $ | 1,363 |
Other income (loss) |  | $ | 183 |  |  | $ | - |  |  | $ | 183 |
Income (loss) before income taxes |  | $ | 164 |  |  | $ | 1,300 |  |  | $ | 1,464 |
Depreciation |  | $ | 163 |  |  | $ | - |  |  | $ | 163 |
Gross identifiable assets at March 31, 2024 |  | $ | 27,542 |  |  | $ | 23,390 |  |  | $ | 50,932 |
Deferred tax asset |  |  |  |  |  |  |  |  |  | $ | 1,840 |
Consolidated total assets at March 31, 2024 |  |  |  |  |  |  |  |  |  | $ | 52,772 |
Three Months Ended March 31, 2025 |  |  |  |  |  |  |  |  |  |  |  |
Operating revenues |  | $ | 2,103 |  |  | $ | - |  |  | $ | 2,103 |
Net investment income (loss) |  | $ | - |  |  | $ | 548 |  |  | $ | 548 |
Other income (loss) |  | $ | 100 |  |  | $ | - |  |  | $ | 100 |
Income (loss) before income taxes |  | $ | (762 | ) |  | $ | 517 |  |  | $ | (245 | )
Depreciation |  | $ | 11 |  |  | $ | - |  |  | $ | 11 |
Three Months Ended March 31, 2024 |  |  |  |  |  |  |  |  |  |  |  |
Operating revenues |  | $ | 2,593 |  |  | $ | - |  |  | $ | 2,593 |
Net investment income (loss) |  | $ | - |  |  | $ | 460 |  |  | $ | 460 |
Other income (loss) |  | $ | 68 |  |  | $ | - |  |  | $ | 68 |
Income (loss) before income taxes |  | $ | (389 | ) |  | $ | 429 |  |  | $ | 40 |
Depreciation |  | $ | 41 |  |  | $ | - |  |  | $ | 41 |

Operating revenues from investment management services include operating revenues from ETF clients of $1.7 million and $5.3 million for the three and nine months ended March 31, 2025, respectively, and $2.2 million and $7.4 million for the three and nine months ended March 31, 2024, respectively. Operating revenues from investment management services also include operating revenues from USGIF of $446,000 and $1.2 million for the three and nine months ended March 31, 2025, respectively, and $369,000 and $1.2 million for the three and nine months ended March 31, 2024, respectively.

NOTE 13. CONTINGENCIES AND COMMITMENTS

The Company continuously reviews investor, employee and vendor complaints, and pending or threatened litigation. The likelihood that a loss contingency exists is evaluated through consultation with legal counsel, and a loss contingency is recorded if probable and reasonably estimable.

During the normal course of business, the Company may be subject to various claims, legal proceedings, and other contingencies. These matters are subject to various uncertainties, and it is possible that some of these matters may be resolved unfavorably. The Company establishes accruals for matters for which the outcome is probable and can be reasonably estimated. Management believes that any liability in excess of these accruals upon the ultimate resolution of these matters will not have a material adverse effect on the Consolidated Financial Statements of the Company. Excluding reserves for uncertain tax positions, the Company recorded no accruals for contingencies as of March 31, 2025, or June 30, 2024.

The Board has authorized a monthly dividend of $0.0075 per share through June 2025, at which time it will be considered for continuation by the Board. Payment of cash dividends is within the discretion of the Company’s Board of Directors and is dependent on earnings, operations, capital requirements, general financial condition of the Company, and general business conditions. The total amount of cash dividends expected to be paid to class A and class C shareholders from April to June 2025 is approximately $300,000.

Page 20

Table of Contents

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

U.S. Global Investors, Inc. (the “Company” or “U.S. Global”) has made forward-looking statements concerning the Company’s performance, financial condition, and operations in this report. The Company from time to time may also make forward-looking statements in its public filings and press releases. Such forward-looking statements are subject to various known and unknown risks and uncertainties and do not guarantee future performance. Actual results could differ materially from those anticipated in such forward-looking statements due to a number of factors, some of which are beyond the Company’s control, including: (i) the volatile and competitive nature of the investment management industry, (ii) changes in domestic and foreign economic conditions, including significant economic disruptions from epidemics, pandemics or outbreaks and the actions taken in connection therewith, (iii) the effect of government regulation on the Company’s business, and (iv) market, credit, and liquidity risks associated with the Company’s investment management activities. Due to such risks, uncertainties, and other factors, the Company cautions each person receiving such forward-looking information not to place undue reliance on such statements. All such forward-looking statements are current only as of the date on which such statements were made.

FACTORS AFFECTING OUR BUSINESS

The Company's business activities are affected by many factors, including, without limitation, market volatility, investor sentiment, general economic and business conditions, interest rate movements, taxes, inflation, labor costs, competitive conditions, and industry regulation, many of which are beyond the control of the Company's management. Further, the business and regulatory environments in which the Company operates remain complex, uncertain, and subject to change. We expect that regulatory requirements and developments will cause us to incur additional administrative and compliance costs. For a discussion of risk factors which could affect the Company, please refer to Item 1A, “Risk Factors” in the Annual Report on Form 10-K for the year ended June 30, 2024.

BUSINESS SEGMENTS

The Company, with principal operations located in San Antonio, Texas, manages two business segments: (1) the Company offers a broad range of investment management products and services to meet the needs of individual and institutional investors, and (2) the Company invests for its own account in an effort to add growth and value to its cash position.

The following is a brief discussion of the Company’s business segments.

Investment Management Services

The Company provides advisory services for four U.S.-based exchange-traded fund (“ETF”) clients and receives monthly advisory fees based on the net asset values of the funds. Information on the U.S.-based ETFs can be found at www.usglobaletfs.com, including the prospectus, performance and holdings. The Company also serves as investment advisor to one European-based ETF and receives a monthly advisory fee based on the net asset value of the fund. The European-based ETF is not available to U.S. investors. The ETFs’ authorized participants are not required to give advance notice prior to redemption of shares in the ETFs, and the ETFs do not charge a redemption fee.

The Company also generates operating revenues from managing and servicing U.S. Global Investors Funds (“USGIF” or the “Funds”). These revenues are largely dependent on the total value and composition of assets under its management. Fluctuations in the markets and investor sentiment directly impact the asset levels of the Funds, thereby affecting income and results of operations. Detailed information regarding the Funds managed by the Company within USGIF can be found on the Company’s website, www.usfunds.com, including the prospectus and performance information for each Fund. The mutual fund shareholders in USGIF are not required to give advance notice prior to redemption of shares in the Funds.

At March 31, 2025, total assets under management, including ETF and USGIF clients, were approximately $1.2 billion compared to $1.7 billion at March 31, 2024, a decrease of $548.2 million. During the nine months ended March 31, 2025, average assets under management, including ETF and USGIF clients, were $1.5 billion, compared to $1.9 billion during the nine months ended March 31, 2024. At June 30, 2024, the Company’s prior fiscal year end, total assets under management, including ETF and USGIF clients, were approximately $1.6 billion, and decreased $372.2 million during the nine months ended March 31, 2025.

Page 21

Table of Contents

The following tables summarize the changes in assets under management for USGIF for the three and nine months ended March 31, 2025, and 2024.

|  | Changes in Assets Under Management |
|  | Three Months Ended March 31, |
|  | 2025 |  |  | 2024 |
(dollars in thousands) |  | Equity |  |  | Fixed Income |  |  | Total |  |  | Equity |  |  | Fixed Income |  |  | Total |
Beginning Balance |  | $ | 226,846 |  |  | $ | 53,324 |  |  | $ | 280,170 |  |  | $ | 233,187 |  |  | $ | 56,722 |  |  | $ | 289,909 |
Market appreciation (depreciation) |  |  | 41,866 |  |  |  | 481 |  |  |  | 42,347 |  |  |  | 6,985 |  |  |  | 242 |  |  |  | 7,227 |
Dividends and distributions |  |  | - |  |  |  | (437 | ) |  |  | (437 | ) |  |  | - |  |  |  | (480 | ) |  |  | (480 | )
Net shareholder purchases (redemptions) |  |  | (3,453 | ) |  |  | (1,195 | ) |  |  | (4,648 | ) |  |  | (10,728 | ) |  |  | 334 |  |  |  | (10,394 | )
Ending Balance |  | $ | 265,259 |  |  | $ | 52,173 |  |  | $ | 317,432 |  |  | $ | 229,444 |  |  | $ | 56,818 |  |  | $ | 286,262 |
Average investment management fee |  |  | 0.79 | % |  |  | 0.00 | % |  |  | 0.65 | % |  |  | 0.81 | % |  |  | 0.00 | % |  |  | 0.64 | %
Average net assets |  | $ | 249,043 |  |  | $ | 52,452 |  |  | $ | 301,495 |  |  | $ | 219,813 |  |  | $ | 57,103 |  |  | $ | 276,916 |

|  | Changes in Assets Under Management |
|  | Nine Months Ended March 31, |
|  | 2025 |  |  | 2024 |
(dollars in thousands) |  | Equity |  |  | Fixed Income |  |  | Total |  |  | Equity |  |  | Fixed Income |  |  | Total |
Beginning Balance |  | $ | 233,296 |  |  | $ | 55,102 |  |  | $ | 288,398 |  |  | $ | 265,329 |  |  | $ | 63,110 |  |  | $ | 328,439 |
Market appreciation (depreciation) |  |  | 45,324 |  |  |  | 1,563 |  |  |  | 46,887 |  |  |  | 3,781 |  |  |  | 1,618 |  |  |  | 5,399 |
Dividends and distributions |  |  | (7,591 | ) |  |  | (1,398 | ) |  |  | (8,989 | ) |  |  | (2,235 | ) |  |  | (1,517 | ) |  |  | (3,752 | )
Net shareholder purchases (redemptions) |  |  | (5,770 | ) |  |  | (3,094 | ) |  |  | (8,864 | ) |  |  | (37,431 | ) |  |  | (6,393 | ) |  |  | (43,824 | )
Ending Balance |  | $ | 265,259 |  |  | $ | 52,173 |  |  | $ | 317,432 |  |  | $ | 229,444 |  |  | $ | 56,818 |  |  | $ | 286,262 |
Average investment management fee |  |  | 0.75 | % |  |  | 0.00 | % |  |  | 0.61 | % |  |  | 0.81 | % |  |  | 0.00 | % |  |  | 0.64 | %
Average net assets |  | $ | 245,983 |  |  | $ | 53,978 |  |  | $ | 299,961 |  |  | $ | 231,059 |  |  | $ | 58,926 |  |  | $ | 289,985 |

As shown above, USGIF period-end assets under management at March 31, 2025, were higher compared to March 31, 2024. Additionally, average net assets during the three and nine months ended March 31, 2025, were higher compared to the corresponding periods in 2024.

During the three and nine months ended March 31, 2025, USGIF period-end assets under management increased, in contrast to a decline during the same periods in 2024. The increase during the three and nine months ended March 31, 2025, was primarily due to market appreciation, while the decrease during the same periods in 2024 was largely attributed to net redemptions. The net redemptions during the nine months ended March 31, 2024, were driven largely by equity fund liquidations.

The average annualized investment management fee rate (total advisory fees, excluding performance fees, as a percentage of average assets under management) was 65 basis points and 61 basis points for the three and nine months ended March 31, 2025, respectively, and 64 basis points for both the three and nine months ended March 31, 2024. For the equity funds, the average investment management fee was 79 basis points and 75 basis points for the three and nine months ended March 31, 2025, respectively, compared to 81 basis points for the same periods in 2024. The Company has agreed to contractually or voluntarily limit the expenses of the Funds. Therefore, the Company waived or reduced its fees and/or agreed to pay expenses of the Funds. As a result of these fee waivers, the average investment management fee for the fixed income funds was minimal.

Investment Activities

Management believes it can more effectively manage the Company’s cash position by broadening the types of investments used in cash management and continues to believe that such activities are in the best interest of the Company. The Company’s investment activities are reviewed and monitored by Company compliance personnel, and various reports are provided to certain investment advisory clients. Written procedures are in place to manage compliance with the code of ethics and other policies affecting the Company’s investment practices. This source of revenue does not remain consistent and is dependent on market fluctuations, the Company’s ability to participate in investment opportunities, and timing of transactions.

As of March 31, 2025, the Company held investments carried at fair value on a recurring basis of $13.3 million and a cost basis of $16.5 million. The fair value of these investments is approximately 27.3 percent of the Company’s total assets at March 31, 2025. In addition, the Company held other investments of approximately $1.7 million and held-to-maturity debt investments, net of allowance for credit losses, of $929,000.

Investments recorded at fair value on a recurring basis were approximately $13.3 million at March 31, 2025, compared to approximately $15.5 million at June 30, 2024, the Company’s prior fiscal year end, which is a decrease of approximately $2.2 million. See Note 2, Investments, in the Notes to Consolidated Financial Statements of this Quarterly Report on Form 10-Q, for further information regarding investment activities.

Page 22

Table of Contents

RESULTS OF OPERATIONS – Three months ended March 31, 2025, and 2024

The Company recorded a net loss of $382,000 ($(0.03) per share) for the three months ended March 31, 2025, compared to a net loss of $35,000 ($(0.00) per share) for the three months ended March 31, 2024, a change of approximately $347,000. The change is primarily attributed to a decrease in operating revenues, partially offset by a decrease in operating expenses and an increase in net investment income during the current period compared to the same period in the prior year, as discussed further below.

Operating Revenues

Total consolidated operating revenues for the three months ended March 31, 2025, decreased $490,000, or 18.9 percent, compared with the three months ended March 31, 2024. This decline was primarily driven by a decrease in advisory fees of $494,000, or 19.3 percent, which resulted from lower average assets under management in the ETFs and a decrease in base management fees earned. Advisory fees consist of two components: base management fees and performance fees. The reduction in base management fees was the key factor contributing to the overall decrease in advisory revenues as detailed below:

| • | Base management fees decreased $526,000. The majority of this decrease was from ETF unitary management fees, which decreased $567,000 as the result of a decrease in ETF average assets under management, primarily for the Jets ETF.

| • | Performance fee adjustments for USGIF in the current period resulted in fees paid of $69,000 compared to $101,000 in the corresponding period in the prior year, a favorable change of $32,000. The USGIF performance fee, which applies to the equity funds only, is a fulcrum fee that is adjusted upwards or downwards by 0.25 percent when there is a performance difference of 5 percent or more between a fund’s performance and that of its designated benchmark index over the prior rolling 12 months. This performance adjustment began to be phased out during the fourth quarter of fiscal 2024 and will cease during the fourth quarter of fiscal 2025. During the phase-out period, the adjustment for the performance fee can only be adjusted downward.

Operating Expenses

Total consolidated operating expenses for the three months ended March 31, 2025, decreased by $85,000, or 2.8 percent, compared to the same period in 2024. This decrease was primarily driven by a $281,000, or 16.2 percent, reduction in general and administrative expenses, largely due to lower ETF and USGIF-related costs. The decrease was partially offset by a $146,000, or 150.5 percent, increase in advertising expenses, primarily attributed to increased efforts to grow ETF assets under management through targeted advertising spending.

Other Income (Loss)

For the three months ended March 31, 2025, total consolidated other income was $648,000, an increase of approximately $120,000 compared to $528,000 for the same period in 2024. The primary cause of this increase was net investment income, which totaled $548,000 for the three months ended March 31, 2025. This represents an increase of $88,000 compared to $460,000 in the corresponding quarter of the previous year. The primary factor driving the increase in net investment income was a decrease in net realized and unrealized losses on corporate investments, as outlined below:

| • | Realized and unrealized losses on equity securities totaled $50,000 in the current period compared to $231,000 in the comparative period, a favorable change of $181,000.
| • | Foreign currency losses were $1,000 in the current period compared to $84,000 in the comparative period, a favorable change of $83,000.
| • | Unrealized losses on embedded derivatives were $1,000 in the current period compared to $22,000 in the comparative period, a favorable change of $21,000.
| • | Dividend and interest income was $466,000 in the current period compared to $595,000 in the comparative period, a decrease of $129,000.
| • | Realized and unrealized gains on debt securities totaled $125,000 in the current period compared to $202,000 in the comparative period, a decrease of $77,000.

Provision for Income Taxes

A tax expense of $137,000 was recorded for the three months ended March 31, 2025, compared to $75,000 for the same period in 2024, reflecting an increase of $62,000. The increase was primarily driven by discrete items, including return-to-provision adjustments, partially offset by a higher operating loss in the current period.

Page 23

Table of Contents

RESULTS OF OPERATIONS – Nine months ended March 31, 2025, and 2024

The Company recorded a net loss of $153,000 ($(0.01) per share) for the nine months ended March 31, 2025, compared to net income of $1.0 million ($0.07 per share) for the nine months ended March 31, 2024, a change of approximately $1.2 million. The decline was primarily driven by lower operating revenues in the current period compared to the same period in the prior year, partially offset by higher net investment income, as discussed further below.

Operating Revenues

Total consolidated operating revenues for the nine months ended March 31, 2025, decreased $2.1 million, or 24.0 percent, compared with the nine months ended March 31, 2024. This decline was primarily driven by a decrease in advisory fees of $2.1 million, or 24.3 percent, which resulted from lower average assets under management in the ETFs and a decrease in base management fees earned. Advisory fees consist of two components: base management fees and performance fees. The reduction in base management fees was the key factor contributing to the overall decrease in advisory revenues as detailed below:

| • | Base management fees decreased $2.2 million. The majority of this decrease was from ETF unitary management fees, which decreased $2.1 million as the result of a decrease in ETF average assets under management, primarily for the Jets ETF.

| • | Performance fee adjustments for USGIF in the current period resulted in fees paid of $229,000 compared to $344,000 in the corresponding period in the prior year, a favorable change of $115,000. The USGIF performance fee, which applies to the equity funds only, is a fulcrum fee that is adjusted upwards or downwards by 0.25 percent when there is a performance difference of 5 percent or more between a fund’s performance and that of its designated benchmark index over the prior rolling 12 months. This performance adjustment began to be phased out during the fourth quarter of fiscal 2024 and will cease during the fourth quarter of fiscal 2025. During the phase-out period, the adjustment for the performance fee can only be adjusted downward.

Operating Expenses

Total consolidated operating expenses for the nine months ended March 31, 2025, decreased $144,000, or 1.7 percent, compared with the nine months ended March 31, 2024. This decrease was primarily driven by a $378,000, or 8.0 percent, reduction in general and administrative expenses, largely due to lower ETF and USGIF-related costs. The decrease was partially offset by a $196,000, or 67.4 percent, increase in advertising expenses, primarily attributed to increased efforts to grow ETF assets under management through targeted advertising spending.

Other Income (Loss)

For the nine months ended March 31, 2025, total consolidated other income was $2.1 million, an increase of approximately $520,000 compared to $1.5 million for the same period in 2024. The primary cause of this increase was net investment income, which totaled $1.8 million for the nine months ended March 31, 2025. This represents an increase of $456,000 compared to $1.4 million in the corresponding period of the previous year. Impairment losses on equity securities recognized in the comparative period, which was partially offset with a reduction in realized gains on debt securities in the current period, was the key driver of the overall increase in net investment income, as outlined below:

| • | Realized and unrealized losses on equity securities totaled $149,000 in the current period compared to $1.1 million in the comparative period, a favorable change of $986,000. The nine months ended March 31, 2024, included realized losses for impairments of $1.0 million for equity investments accounted for under the investment alternative.
| • | Realized and unrealized gains on debt securities totaled $449,000 in the current period compared to $886,000 in the comparative period, a decrease of $437,000. This is primarily due to a decrease of $399,000 in realized gains on debt securities reclassified from other comprehensive income (loss), related to the Company's investment in HIVE convertible debentures, as discussed in Note 2, Investments, in the Notes to Consolidated Financial Statements of this Quarterly Report on Form 10-Q.
| • | Foreign currency losses were $193,000 in the current period compared to $82,000 in the comparative period, an unfavorable change of $111,000.

Provision for Income Taxes

A tax expense of $229,000 was recorded for the nine months ended March 31, 2025, compared to $446,000 for the same period in 2024, representing a decrease of $217,000. The decrease was primarily driven by a higher operating loss in the current period, partially offset by increased net investment income and the unfavorable impact of discrete items, including return-to-provision adjustments.

Page 24

Table of Contents

LIQUIDITY AND CAPITAL RESOURCES

At March 31, 2025, the Company had net working capital (current assets minus current liabilities) of approximately $37.5 million, a decrease of $666,000, or 1.7 percent, since June 30, 2024, and a current ratio (current assets divided by current liabilities) of 21.7 to 1. With approximately $26.3 million in cash and cash equivalents, a decrease of $1.1 million, or 4.1 percent since June 30, 2024, and $11.0 million in securities carried at fair value on a recurring basis, excluding convertible securities, which together comprise approximately 76.4 percent of total assets, the Company has adequate liquidity to meet its current obligations.

The decrease in cash was primarily due to repurchases of the Company's common stock of $1.6 million, dividends paid of $912,000, and net cash used in operating activities of $808,000; partially offset by proceeds from principal paydowns of $2.3 million. Consolidated shareholders’ equity at March 31, 2025, was $46.1 million, a decrease of $2.9 million, or 5.9 percent since June 30, 2024. The decrease was primarily driven by $1.6 million in repurchases of the Company's common stock (including excise tax), $900,000 in dividends declared, and $400,000 in other comprehensive loss for the nine months ended March 31, 2025.

The Company also has access to a $1.0 million credit facility, which can be utilized for working capital purposes. The credit agreement requires the Company to maintain certain covenants; the Company has been in compliance with these covenants during the current fiscal year. The credit agreement expires on May 31, 2026, and the Company intends to renew it biennially. The credit facility is collateralized by approximately $1.0 million, included in restricted cash on the Consolidated Balance Sheets, held in deposit in a money market account at the financial institution that provided the credit facility. As of March 31, 2025, this credit facility remained unutilized by the Company.

Investment advisory contracts pursuant to the Investment Company Act of 1940 and related affiliated contracts in the U.S., by law, may not exceed one year in length and, therefore, must be renewed at least annually after an initial two-year term. The investment advisory and related contracts between the Company and USGIF have been renewed through September 2025. The advisory agreement for the U.S.-based ETFs has been renewed through July 2025.

The primary cash requirements are for operating activities. The Company also uses cash to purchase investments, pay dividends and repurchase Company stock. The cash outlays for investments and dividend payments are discretionary and management or the Board may discontinue as deemed necessary. The stock repurchase plan is approved through December 31, 2025, but may be suspended or discontinued. Cash and securities recorded at fair value on a recurring basis, excluding convertible securities, of approximately $37.3 million, are available to fund current activities.

Management believes current cash reserves, investments, and financing available will be sufficient to meet foreseeable cash needs for operating activities.

CRITICAL ACCOUNTING ESTIMATES

For a discussion of other critical accounting policies that the Company follows, please refer to Item 7 in the Annual Report on Form 10-K for the year ended June 30, 2024.

Page 25

Table of Contents

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Macroeconomic downturns, including inflationary pressures; geopolitical instability, such as the Russia-Ukraine and Israel-Palestine conflicts; escalating trade tensions; and adverse market conditions, including volatility driven by investor uncertainty and disruptions in cryptocurrency markets, may negatively impact the Company’s financial performance. These factors could reduce revenue, increase operational costs, and weaken the Company’s operating results, cash flow, and stock price.

Additionally, prolonged or intensifying trade wars, including tariffs, trade restrictions, and retaliatory measures, may disrupt global capital flows, heighten market volatility, and depress asset prices. Such uncertainty could lead to shifts in investor sentiment, changes in asset allocation trends, and increased redemption activity, all of which may result in lower assets under management (AUM) and reduced management fees. Market declines may also reduce the valuation of the Company’s corporate investments, further impacting the Company’s balance sheet and overall financial results.

Investment Management and Administrative Services Fees

Revenues are generally based upon a percentage of assets under management in accordance with contractual agreements. Accordingly, fluctuations in the financial markets have a direct effect on the Company’s operating results. A portion of assets under management have exposure to international markets and/or natural resource sectors, which may experience volatility. In addition, fluctuations in interest rates may affect the value of assets under management in fixed income funds.

Performance Fees

USGIF advisory fees are comprised of two components: a base management fee and a performance fee. The performance fee is a fulcrum fee that is adjusted upwards or downwards by 0.25 percent when there is a performance difference of 5 percent or more between a fund’s performance and that of its designated benchmark index over the prior rolling 12 months. This performance adjustment began to be phased out during the fourth quarter of fiscal 2024 and will cease during the fourth quarter of fiscal 2025. During the phase-out period, the adjustment for the performance fee can only be adjusted downward.

As a result, the Company’s revenues are subject to volatility beyond market-based fluctuations discussed in the investment management and administrative services fees section above. Due to these performance adjustments, the Company realized a decrease in its USGIF base advisory fee of $69,000 and $229,000 for the three and nine months ended March 31, 2025, respectively, and $101,000 and $344,000 for the three and nine months ended March 31, 2024, respectively.

Corporate Investments

The Company’s Consolidated Balance Sheets include substantial amounts of assets whose fair values are subject to market risk. The market risks are primarily associated with equity prices and foreign currency exchange rates. The fair values of corporate investments with exposure to the cryptocurrency industry are subject to considerable volatility.
The Company’s investment activities are reviewed and monitored by Company compliance personnel, and various reports are provided to certain investment advisory clients. Written procedures are in place to manage compliance with the code of ethics and other policies affecting the Company’s investment practices.

Equity price risk

Due to the Company’s investments in securities carried at fair value, equity price fluctuations represent a market risk factor affecting the Company’s consolidated financial position. The carrying values of investments subject to equity price risks are based on quoted market prices or, if not actively traded, management’s estimate of fair value as of the balance sheet date. Market prices fluctuate, and the amount realized in the subsequent sale of an investment may differ significantly from the reported fair value.

The following table summarizes the Company’s equity price risks in securities recorded at fair value on a recurring basis as of March 31, 2025, and shows the effects of a hypothetical 25 percent increase and a 25 percent decrease in market prices.

|  |  |  |  |  |  | Estimated Fair Value |  |  | Estimated Increase |
|  | Fair Value at |  | Hypothetical |  | After Hypothetical |  |  | (Decrease) in |
(dollars in thousands) |  | March 31, 2025 |  | Percentage Change |  | Price Change |  |  | Net Income (Loss)(1) |
Trading securities at fair value |  | $ | 11,003 |  | 25% increase |  | $ | 13,754 |  |  | $ | 2,173 |
|  |  |  |  | 25% decrease |  | $ | 8,252 |  |  | $ | (2,173 | )

1. | Changes in unrealized gains and losses on embedded derivatives and trading securities at fair value are included in earnings in the Consolidated Statements of Operations. The estimated increase (decrease) is after income taxes at the statutory rate in effect as of the balance sheet date.

The selected hypothetical changes do not reflect what could be considered best- or worst-case scenarios. Results could be significantly different due to both the nature of markets and the concentration of the Company’s investment portfolio.

Page 26

Table of Contents

Interest rate risk

Interest rate fluctuations present a market risk to the Company’s consolidated financial position due to its investments in debt securities. These securities are sensitive to changes in interest rates, typically decreasing in value when rates rise and increasing when rates fall. Such fluctuations can materially impact the Company’s debt securities included on the Consolidated Balance Sheets, as well as the unrealized gains (losses) and interest income recognized in net investment income (loss). Additionally, changes in interest rates can significantly affect the interest income earned from the Company’s cash and cash equivalents, also recognized in net investment income (loss).

Foreign currency risk

A portion of cash and certain corporate investments are held in foreign currencies, primarily Canadian. Adverse changes in foreign currency exchange rates would lower the value of those cash accounts and corporate investments. Certain assets under management also have exposure to foreign currency fluctuations in various markets, which could have an impact on their value and thus the revenue received by the Company.

Additionally, escalating trade tensions and retaliatory measures, such as tariffs, trade restrictions, or capital controls, could contribute to currency volatility, disrupt cross-border transactions, and affect the liquidity and valuation of foreign-denominated assets. These factors may further impact the Company's financial condition and operating results.

Indirect exposure to cryptocurrencies risk

Cryptocurrencies (also referred to as “virtual currencies” and “digital currencies”) are digital assets that are designed to act as a medium of exchange. Although the Company has no current intention of directly investing in cryptocurrencies, the Company has indirect exposure to cryptocurrencies by investing in securities of issuers with exposure to the cryptocurrency industry. Cryptocurrencies (some of the most well-known include Bitcoin and Ethereum) are not backed by any government, corporation, or other identified body. Trading markets for cryptocurrencies are often unregulated and may be more exposed to operational or technical issues as well as the potential for fraud or manipulation than established, regulated exchanges for securities, derivatives and traditional currencies.

Cryptocurrencies have been subject to significant fluctuations in value. The value of a cryptocurrency may significantly fluctuate precipitously (including declining to zero) and unpredictably for a variety of reasons, including, but not limited to: investor perceptions and expectations; regulatory changes; general economic conditions; adoption and use in the retail and commercial marketplace; public opinion regarding the environmental impact of the creation (“minting” or “mining”) of cryptocurrency; confidence in, and the maintenance and development of, its network and open-source software protocols such as blockchain for ensuring the integrity of cryptocurrency transactional data; and general risks tied to the use of information technologies, including cybersecurity risks.

ITEM 4. CONTROLS AND PROCEDURES

An evaluation of the effectiveness of the design and operation of the Company’s disclosure controls and procedures as of March 31, 2025, was conducted under the supervision and with the participation of management, including our Chief Executive Officer and Chief Financial Officer. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the disclosure controls and procedures were not effective as of March 31, 2025, due to the existence of the material weakness in internal control over financial reporting described below (which we view as an integral part of our disclosure controls and procedures).

The material weakness in internal controls over financial reporting that was disclosed in our annual report on Form 10-K as of and for the year ended June 30, 2024, was also present as of March 31, 2025. Notwithstanding the material weakness, we believe that the Consolidated Financial Statements included in this quarterly report on Form 10-Q fairly present, in all material respects, our financial position, results of operations and cash flows as of the date, and for the period, presented, in conformity with U.S. GAAP.

Other than as described above, there has been no change in the Company’s internal control over financial reporting that occurred during the three and nine months ended March 31, 2025, that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

Page 27

Table of Contents

PART II. OTHER INFORMATION

ITEM 1A. RISK FACTORS

For a discussion of risk factors which could affect the Company, please refer to Item 1A, “Risk Factors” in the Annual Report on Form 10-K for the year ended June 30, 2024. There have been no material changes since the fiscal year end to the risk factors listed therein.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Issuer Purchases of Equity Securities

(dollars in thousands, except price data) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  |  | Total Number |  |  |  |  |  |  |  |  |  |  | Total Number of Shares |  |  | Approximate Dollar Value |
|  |  | of Shares |  |  | Total Amount |  |  | Average Price |  |  | Purchased as Part of |  |  | of Shares that May Yet Be |
Period |  |  | Purchased (1) |  |  | Purchased |  |  | Paid Per Share (2) |  |  | Publicly Announced Plan(3) |  |  | Purchased Under the Plan |
01-01-25 to 01-31-25 |  |  |  | 35,291 |  |  | $ | 87 |  |  | $ | 2.46 |  |  |  | 35,291 |  |  | $ | 4,913 |
02-01-25 to 02-28-25 |  |  |  | 88,820 |  |  |  | 218 |  |  | $ | 2.46 |  |  |  | 88,820 |  |  | $ | 4,695 |
03-01-25 to 03-31-25 |  |  |  | 63,876 |  |  |  | 149 |  |  | $ | 2.33 |  |  |  | 63,876 |  |  | $ | 4,546 |
Total |  |  |  | 187,987 |  |  | $ | 454 |  |  | $ | 2.42 |  |  |  | 187,987 |  |  |  |  |

1. | The Board of Directors of the Company approved on December 7, 2012, and has renewed annually, repurchases of up to $2.75 million in each of calendar years 2013 through 2022 of its outstanding class A common stock from time to time on the open market in accordance with all applicable rules and regulations. On February 25, 2022, the Company announced that the Board of Directors of the Company approved an increase to the limit of its annual share buyback program from $2.75 million to $5.0 million. The Board of Directors of the Company approved and has renewed annually, repurchases of up to $5.0 million in each calendar years 2023 through 2025.

2. | The average price paid per share of stock repurchased under the stock repurchase program includes the commissions paid to brokers.

3. | The total amount of shares that may be repurchased in 2025 under the program is $5.0 million.

ITEM 5. OTHER INFORMATION

During the three months ended March 31, 2025, no director or officer of the Company adopted, terminated, or modified a "Rule 10b5-1 trading arrangement" or "non-Rule 10b5-1 trading arrangement," as each term is defined in Item 408(a) of Regulation S-K.

Page 28

Table of Contents

ITEM 6. EXHIBITS

1. Exhibits – |
31.1 | Rule 13a-14(a) Certifications (under Section 302 of the Sarbanes-Oxley Act of 2002), included herein.
32.1 | Section 1350 Certifications (under Section 906 of the Sarbanes-Oxley Act Of 2002), included herein.
101.INS | Inline XBRL Instance Document
101.SCH | Inline XBRL Taxonomy Extension Schema Document
101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB | Inline XBRL Taxonomy Extension Labels Linkbase Document
101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document
104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

Page 29

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereto duly authorized.

|  | U.S. GLOBAL INVESTORS, INC.
DATED: | May 8, 2025 | BY: /s/ Frank E. Holmes |
|  | Frank E. Holmes
|  | Chief Executive Officer
DATED: | May 8, 2025 | BY: /s/ Lisa C. Callicotte |
|  | Lisa C. Callicotte
|  | Chief Financial Officer

Page 30